var title_f26_35_27184="Nonnutritive nutritive suck";
var content_f26_35_27184=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Non-nutritive versus nutritive suck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 394px; background-image: url(data:image/gif;base64,R0lGODlhMwKKAfcAAP///wAAAH9/f4CAgMDAwEBAQD8/P/7+/uDg4PDw8NDQ0KCgoL+/vxAQEDAwMCAgIHBwcJCQkJ+fn2BgYFBQULCwsN/f38/Pz19fXx8fHw8PD+/v729vb/39/S8vL/Hx8X5+fvv7+/r6+uzs7Hx8fE9PT/X19fj4+Ovr69ra2q+vr+7u7vLy8u3t7Y+Pj/Pz8/z8/Pb29vf39/T09FhYWOrq6tvb22trawYGBtjY2MzMzOnp6VtbW2VlZcfHx6ysrHR0dHJycoaGhtfX1zg4OHV1dcbGxujo6Pn5+aqqqmxsbEhISCoqKlpaWtnZ2cTExOXl5bq6uiQkJHl5eZaWlsvLyyUlJQ4ODhoaGqWlpc3Nzbi4uNPT03Nzcy4uLh4eHt7e3hcXF+fn54GBgZ2dnVFRUeHh4ZWVlVVVVU1NTX19fUlJSebm5tzc3B0dHWpqakFBQXt7e8XFxVdXV1xcXCwsLBQUFAEBAdLS0nd3dwwMDIuLi3h4eERERDQ0NMPDw9XV1RwcHN3d3b6+vnFxcbe3t2lpaeLi4q6uro2NjSkpKQsLC15eXqSkpOPj4729vZycnNHR0ZKSkm1tbU5OToSEhFRUVEVFRRgYGLm5uRYWFkZGRp6eni0tLbu7uyEhIUxMTFJSUo6Ojjc3N62trTExMXZ2dmhoaAcHB2FhYZmZmTo6OiYmJjU1NbGxsYmJiQoKCrS0tKenpycnJzw8PM7OzqKiojY2NiIiIgQEBBMTE3p6era2tpubmygoKGdnZxUVFbKyslZWVqmpqcHBwYeHh7y8vOTk5Kurq8jIyNbW1oKCgpOTk1lZWaampsLCwmNjYyMjIzMzMwMDA8rKyj09PTIyMktLSxkZGRISEgUFBV1dXT4+PhERETk5OZSUlENDQ7W1tUJCQoODg4qKilNTU0dHRysrK2ZmZpGRkQICAqOjo5iYmA0NDRsbG2JiYoyMjLOzs5qamoWFhWRkZKioqMnJyZeXl4iIiAkJCUpKStTU1KGhoW5ubjs7OwAAACH5BAAAAAAALAAAAAAzAooBAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUs2AQECCBgquDsQAV6aCwosOAihgIKVCgpAMFigAMYEFAzn9Hv37mHIkulqxrogQIAJDAt4HiBwQADSKEUTQBh4MIEAjgUWPqzydWyCjTFSOJ3QtkvTnj3Hfv0gwebjVEUHaGBcofIAh02jBuCXdkEF1hP6DR1g9ULfEO/m/z1ol0Dz7+YBgF+4neDe8wWJx/+rHrb7u/DVeydI2aLpBwMEOJhAE/CG3IFOIeDZAwEMmJBoDQRQnHQAJPDcA4cR54BnFCDE4YLGUQiAZwAAN9prDkDQQIC8BUeiahUE4IBsASxWQYSeLVZQBC5GAIBq9cVmInS+mdbAYSSOGMBuEhqXwIbLJUlQgT4KRACOSyoZ3I8uggaAAjhG6BhkwWFoUGGNpakjQaY5QEB2X0qI4JxL8Zhils41GCEEFBZIAQH/1dcABBB4lmFleXk2wQAR+igiiQQwuOhdnjkgWJ8SBsjlahHmxaACCDTQQAUVfOqehHfxuWmQAHQ2agV/2v8WY3cCJakoowH4WKCbsxpkqkARVkBABB0WCCBpAyxAwAIRHiYpoPYVOgEBhXZYEJppKmbQkGYO1Cmd4Bq1YQQKeJZfQap1JiNvETa34V72reoiaUlS+GgAAgHJamm8rQdkoeTKCACPBQQo2nRxwjaAd0D6tpuD9T3Q6EC24ltiiwE0JyXFFgMrIwQDrpfAAoVFSOmMrEYYIHAULUtABRs+gBut4dYMVLku5prnakxiPJBq4AG58sJK8ousgUnqux6F/tJa7p2D/ZctxCViSVrD9ulrpWcRWlv01xRKuXGtHQNQanCOrbdhwQxSOpx9wmV7ZraNrXnQa2VrbfPeOhX/eqxoKDcGJ5AJ4EjahqsVnnHQNBdUL2+mdaigxaJVsPVtTAucL80xZ2w2bM21J9B2CpjmmGg+duZYoTqCiqLiln/9+OE6T27QtwINhkCvKF6+uXmGtmrfhrG3OjfddpdmeQLGEvQr39DfxGCVOCfa+O8CzUrarAXsua/eHBtdX84ELlfw0rxN7oDM+vL42c/mb4gwcQUweLSLjoUqI9D2xdiA9WQT36xcZJCHUawBBVgbdSr1APVBaTWFwt/4LBUhijzHM8VTUAOix8GaJCBA4ynRAKIzgBDmroQDiQDR1DOBAlBgQAhI1glNOBBNqWeFgaFA6VCTADRVIIYOApR3/2DlwlahsEIBys4CIlMwEyYgAo2hQOw+WIAJlA6GaIJAAoAoEBVazoY2FOLokjg24d1miY2pktki0yECUECKCzgioCKgutGhaQJUewi1GjMtNr2vg4AMZFEIkKIBSOogG8pjRAZQMBU1qCSh+p8gJ0nJnigASg2YwLm+JCo4RWQBDMpUSZ70yEqa8pSoTKUqV8nKVrrylbCMpSxnSUtT2oWGtcylLnnCvAhl0iGAystrELbLYhqTJuMa1gYT8p6L7YcgbzIIfY5JzWqCxDMLyItxRLO5L4UyV2gbJicrZRwJ4ah41kynOisSQQkNhptc4tJhIkAAKsHrcMx5zWIkVP8Bgq3znwANDwSglBjK4Ste/FqNOOMFt9ggNKAQjWgN3QUd0SiAlAB4QHG+FENaiVOjCwQNQ28jUVmyYQclfYhwNgQaE1WwMw9Il4SmxZvOrO9II3IoSVO6lhwIQADKqIgNIMIMdBjCCDxlCALiOMKBxFEBcRydCgcUxx+usHQRGI8MS6RIpVBBACgoyAteIJIYAKAFFzHrBw6QkGSQYgHJcIsTDiIAGniGBgypAToBcAAB8EAIBbHAT014Ak7YwTPmMMgMuPDTDSikBlQ4hFFCgIQTxMCxScXIEdqQghkAwAJQ2IAnwhCAGwiAIEAAggCYMRAw/PSnBGFAI376B4L/+OC18CiIAPIggEkI4BUIea0AakFX3gZBACsoiBl+uoZOfGINAiDrTaJAkA7oIAWCAMMFAAAGPBgBAUPIAgM48dsk1MKsSJABQj4QgoGI4Qk/aIQOTAAAGIgABgCYa0GyEAApCCAAdxCIAl4bVoGMQQBvcEAsBvJTz+BgIFoQAAYURZApZCAAbxibAIpgiRwdJBg/fUMY3gEJhrwABUeAAgIQ4IRCyGIdMFYFJHrxjW+4IBF7mEcxhMvjHv+UGZVgRjheu44fkEIVAiCHLYTwWhLsYgp5gACPEzGGcaRjGFHAL0GQYALpFqS9O1gBFJChgliQYgcwOAEAQtCB9Mag/w2NkIQo5jEOKJjyGD7+6Sno0IQiSLgHEKBFAKbgmSMIBA8ByEUA7DAQRgRgEZ75gEBSUAApeKYPBFlCcNqxXY45AA0BgIUA1EuQM7ioBAYZRABw8Ak4BIADBUmFZyix4XMEAAh4IAgbnrCOPPv618D+9SqEC4I0NGEbjKCAABhRDnNMYA5WKMCFYcGEEvB2F3zIcxBI8NpfXKIOUkiDKQSghjioQQCV6LEVAtAIJYkAAGUIjjMEcog7BAcNAvGBZ9QgJUoEYA7/DUAHBMKC/gqgBpoIgBgG4gTPbEIAvgiAFr5sDc98ggMBcEMlBuJZALyAHa8Fwg1O0YMJTKAZo/+YRTRWjgU3BAIYwGjAFfSgDVQERwqzYIJnAqGNnHnGDrmwQyuCE406dAILj8YFDjyzCgOYowSrWEInXHSFO0wjG4pYxbkFwGQB7MIUqu0xtw3BgR6cwwN+6IQh1DAFAZAABNjOAx2koAsNaGMawTClMtyRMz0wIQOhoIE5HPCFDHCjHD0QwAmuEYBMCCQIAaiEGwLwbiWRgxsBsDMAehCAn7IiAKTeQQCIIAAl1GggQwgAKCoACAH4mw/zHkjCG1w2gRggAEJQVjcCkIOBmCAAVhDAxGeAjC4EoBzCRcclouGifNjb5y6yeQDUkTNMfAET7sBFHaygiE9YwQtMYEL/GOrgBweMohWrKIA0NrGETXyiDmsIBSVoUQdutGIJRZgDB14bB24LgALVQATc0Ade4HNLQAT6EApNwAPQ8AvQgAE9MAfXZwDrpmjBsQjuIA6nBQBTFwdgEACj8F9KIBCScGv/dQkCwXgCAANJcgQBYAlDoCSk1hljIBB2pQIDMQ4BgA5yAACcEACUUBBPMHoCsAArIAB1kAsCsAcb9lNAgA0BoAlMUADi0Ax0gAbNYFrBxmONIAtJ8FO9MA9bCGxRMAhGUAtR4AOkkGcggAYa4GCeoQfi4A3Q5wC0cH7eQAMCUAZwAA5E0AphoAGzEAZMsAmUAA3CpQPA9ExRwRcl//EB8sBje5AEnBAJOWAEFUAGnPAIeKB5SRAAiSAQDAIAsmZoI+IOAAAPAXAMAgFpNsh7AgEEAbAFADACciIQcxAAVQBhGMcK1CAQwRAAzSAQS2dWA8GCbjAQexAAeCUQ8xAAWVAQLLALsHCBXvAOPIYPB/ZrOyYAy8Bj90AG9yAPtvADWTAMC5AFiJAESUAFPxALFVAI4RAFDBAPcuADcrAAP5AMkaAFnvADjxAOPjADQ5BcAiEC7QUAF2AMW/AIf4AIPeYDW2APkZACNuAIYuAIoDUE4jgIWdBj5CAPxDAQpOAZjvYDIwIOAuEBAUBWAUALAoEJGSAQ02Ax/LWLSv9ijAUYgwAAeekwEIoQAGwgECYAhfZAEHkQAJxAED/AknoQABlAWtigWmeQBAxADE7QBoDgBAXmEx0ACKIgicSQCT5WAZ4gj5nQe3vxDFsQDlQgCrJABUkgB1rgCBLBI0EkGAKWLcmDEDDDIcaRGGrSEYmhI7PBGjqTE38QAD0gEPYGAEnZBnwVAJhGBroYQBeDkgDgipj5NQNxhAFwDQJRcfqFcbxVYgCgBQEwggKBBFLyhgeBBK/wWuSACJJFFmylEHblGZ4VANkQQAcQAJggEN+wlACwdAIBasboGdLlGZXHeWq0MVQQAPqQZCuZeQWhAq/FCV/FDl4WLoXjNcr/gRqvgUDawhADsCjTIyh1gxB/ITqj4x3T5DurQh2MOAHMkRNVEAB+EEB0EACRAABisIMA8IkbNyIPBgCFEACS0JmCtoGrdhAX9gSeeQT+lnHzRg8BQF0DEXF2+QJRaDM54BkYEEAxQCLBWXsAQH0x2THm0pmEEAC51Zn1tQaesQg0Wkk8EkKMZCAoMp8NUSiuISNAyiUbsiIehiKKcqQmxDiroS6jMTqJeRNc8GgAIAIBoA0AUAQBYAz1wQ8AEAWaEwDSIBAN9w21gqMC4QkkUgMBIA4HMZ080AYBAAcEEWEkEACsAACH1ZUAYGpqAAA6EADvsDc/ZQEAcAIBcAXc/yWck6miFTMQuBAAdumZ6xAAkyAQLogKBZEMAjALAWAGI6IBqUQBMuNH5Nkj/LEyjKgkbxMcarQ5cQQbkYIvtlGrszo/PocXTSJOoug1NmEBVqogvgAA01lbnZECAGAEcmKLQEBvAXAKAOAIo0cQkwoAEsCgB3Gi0aCDg2AQIUAiY2OLWAAAxuel0aOowAAAjxCajyoQE2eiUtIMAcALAHAMARAGA2EGAVCsqRkAXnAQ6RAAqfBf5ZBKuYGqArFF4+MeaZJH0LIYDIs36GKrvMFN4oSxBrI1x9I24uSrP7JTNAGiOIoIAfALAPBfI+kCAUBfA1quwxAAtrCwAYAFMP+QCQFACAQBDQGwAjwQAAzgIe1ABAGgZY4TAB/IqAXBfCzAd5gVPQHAqd8QAGfwrsRACQlJIgqSDwMxBrgHAPwFDQOBpRbDD39UEDsADsERtKiUQAUhItFUng3xQwNjH3G7HBVbH1djsXurt9AUL6pRLqABspaSE8G5CJFgo54AALJYDwAAauFTCQFAoQKxbtTgDAGATswgs9sQADxpEJ6RDSoqENIQAFxKBwbBpVtQRjbjmlrKed8KAFCIAj+bkKT1AanHBAPxA6oHADE6sxxjDI1QDaVkEM8gAO5QBpV3SqZxHvUjIY4xJF1VscHxRS5CNRrbtxnLt38bG0CyNir/Q7PEVBMZFwqeQV+mVmKwKRCTOgMxilICwaUkgHEjQBCRQKaCZpCguyUHYZmkFa8EwQsBcAlk2kGuCwCjEABBBQC/EADPAIUDIWg68IGNKRD8qgsqsCGKOBBcWg2WJpQKIQ+eREkKMh1DQxojk0QOgQAqdEQp3FQFEVUx9KSkMcNGRB0rNEZUhUJPNAA8UiWmgUs04Zv8Gw8BwA6eeQoBUAP+UDY4OwafAKlZOrpkU7MIUQOKtgYHga+egQiARCK7hwQCsaCf2DFN0HiDWoMcw5ItSxAzcKGsG0uFMsJHkSbLkRdg0pfkGxwBG6YBQAKeibkosHsE8YGIUJMGUbpx/6wlb5AQ6RZXBxEcyxs9ugCKUjKi5CAlpoYBlonEAwEMwdENBhFh/JtLHxSrSgEoydIcKrRJNKFp4CAAXtyoHuCZQ5h6ZbMCDVJGkOAZUpAQwYFUE8E1gVSCVyAlKVBaUjI5/8kFBMF4noEOCKFpQZBZfHNbz1AQ1ZiiA0Gny7AxitoHZcQGnoG6CIFxbTwRaRAApiBIuxcAtzAQI+ponDoQoIp0pEacwXGUB3FbkmbNgWQIAbCgHaOoUVx75ruoBtEBnsFaCHGEGzgROiAAQxlIt+AZyDAQthiU1UAQ3zw29uAZa/CdAI1Kwkq000AQwVHPA4EzcGoQAjAFQwVRA/8bAB1XxS5AEClQBwFQCgWBAgHQCZBc0qs0YQFQByrtGa1QEAwNigihZhGFAtl2tAGgX7srAK4A06RA1K0krAFQogPBdwGQB/tLxymVzxxDxVydS54hCgQhD55RtQXBA1aA1mtdxXdNTUjXe0mtmQRhA9GY1wRx0IJtTEhmEIclqoWtEFMLrItNTcxQwY+NECwgAJ022dWkeZi92Zzd2Z792aAd2qI92qRd2qZ92qid2qq92qzd2q792rAd27I927Rd27Z927id27q927zd277928Ad3MI93MRd3MZ93Mid3Mq93Mzd3M793NAd3dI93dRd3ZrRAQeQm3yFENrNERL/IACIqhTfHd5JMd5LYd7lDd5aocpDk1MX8RpeEhFPkp80gd3a3d0Egd8acXtsmxT8vRT/rRQBjhQDfhVDAilm7RAPgDITUTjxHRYFfhQRbhQTXhQVPhQXThX+shiBoSINQACi4SUFNSgxTDMIwCQOcFEFsiSBySTWEsRfod0Brt9CkeE1DrQAjuP+rePrjVD2YTqFMijvAgAN4CYFgk74ORC7ISwQoAAUMCo8shgSQyooUy7TaxUyruM0HhQ2zuU8TuBfHhFbzhJd3og+Hr208uPdQT/ygxu3EeQFMyLmSaun5zjj2xIJwACXnRCCJQEOgd4LUeaArhCDnhCFfhB9/94QZY6t6r0Qh47oAuDnC5HoDFHmlO7ojY7p5G3oma4Qlh7pBqHfjx5YoM4Qo04Qny7ppt7pCHHqJLEear4asV4usTKfCVshJDM9DfAAlYEddR5CGwsTr2EADMEAAUDsis7jY57hubnozh7mB2HsyB7o0H4QZb7o0l7sx57s/Z0Q2V7p1W4Q1x7uBVHm307t3Y4Qqjbtnk7uA2Hu287t4J7uKAHraC7r9w4ALDUAFIAwhfIz/b7khVIwE9AhG0Ioy/Qae+USw67t7N7u/b3s5N7s7v7uFW97F3/uEC/v6C4QuZndHr/dGo8QI48Q8P7wJn/xADDu9G7tGR/vBYHfZf++7hy/8QtR8inf8uWu8iBRmD/D4ZKhLYFxGVBURdnxGgNCRFKUO2y0PEWPGvjpyivxGhkQbBNW9Vt4YRiQ9V8dbFrP9Vvv9V0PbFcP9mYPbF9v9VCp9liP9mP/a2Uv9mHv9nPva2lP92x/9nC/9nLf92TP937/a3fvazp/E90j9QtRLnfeEngDfY7/+JAf+ZI/+ZRf+ZZ/+Zif+Zq/+Zzf+Z7/+aAf+qI/+i4S0TyBAOcp329UEwgwhq7/+rAf+7I/+yAw+7Z/+7if+7q/+7zf+77/+7pf+NSd3cRf/GNOFB//8dt9FMfvEfgN8hhh/NC//NZtSskf8s3fE9kPEcT//xDTbxHSv/0MIf7VbzPXv93kDxTdTxLfXxHhPxDp79nrn1Tnz1bxbxbtTxHvL9ogDxAHAAwkWBDAAYQCDRY8YQPMQogRJU6kWNHiRYwZNW7k2NHjR5AhRY4kWdLkSZQpNyI8SDGhQojEZBHqUfBAhwMCBOChuALBjohkdJpQWdToUaRJlS5l2tTpU6crdC4UMGBAi4JJzC3RhMNmBxABApSbmIjDBEMQBXwRmwXqW7hx5c6lW9fu3YkcxNooWEzsnQoFmWiTJ9agkADgxEKReEVsgBAGewXwIyDAKryZNW/m3Nnz56NIHgcriCoAkADFCG4I8AWA4dU4NDwrFyBR/0QtASDoCjDCYKAAsV4vMphDpwDSoJUvZ97c+XOUKgJoCLCO4KEA1V4EuEFQVQABrwMUPBMgDwA8AWZBrEEpwIYMASwU9BHA3EDYA0XQeGwtPHQAUYpHAOECNPBABD9qJYBQAoiAIMu2eA2zgRQJwAzxCrIigCPwG2+hNwJABwDqHCloiQCM8DAG70TUCZcA2Elwxohq0Akog8aRhrJwJPKNRiCDdE6sBQKQhCA3AhDhNS8GaiGAdgZyjCBlAlCEoPwIqiSAAtgAwI4A9ikoPwuTIYgtLwGwJQBsJFTqBKKQYIEogg7wIZMahAypjRADSKugZKYJYI4AWolIACUE4P9FT0YbvWuHxLgIoJKBWPsEP3cGkiQAegYCjiBhAhgGywA+KEiAXDRgYCC25FgtACsIIiGAVwY6ptBT2yFCAFcj+iCKXnQah6+LVqgiihpq0WkKUwTYpYtmjxNgCW/eIMCJVwRYZgtAJuogQTkEUAEiEegIwJIsAVgjAA6GSHcgah67BStH67XXKWQC4MWEANYYqIIASABANEwGkiKAIaQMIAEPC2IlRYJiEEsUgoBzgqCwVCEo334GSiQAMgyCx4EANvmvIHsECGIV4AKYhged9iBmhojwEIADUFZ5owSxWJmlFCb8yOaxAAKxJFQ4moElAHWIQEOA+SD6ti4VBKD/eSIRBNhjoU0C8OCJhV4JQBxJPyR1hQwXQreLroW49224TzqhIHECYOGAAHAZqIAA+GIjgILTFk9MIwLopKBdUiMIngB4KCg+HAFw7AWCGAiAkoF8CUCMhSqwDLw/bDghCgH08fqXKXQqIr4A9BCniOOKkbY2RZq4ARQKQBDAGVlcSSKWdKTthQtlBJCGiDh0AkExDATpzAkPAiiioDFOHoiM1g1K4LFL/jDIMWIEB2B74sSDiaB87JaDzbjbd58jqaYwteHXrqB/BMMsCIAVgh4IEwBCMaMgjwjAKAgCjL4VpBQB0MJAPpClv2GDfmqxUB94MIVVBKAU4hLD3AAw/wNOHAcIfUBgAEzzGCsIYBgpQEEVLjA1i8RjC0sCQAee0YMAbKMzzXgMiwDghDsEIAoFgVEAUFCQTS3BMn2owpg+lKVCBIARA+lGAOhEkCc9MQBIeF8XvSgRvQQgCaRq2JOu1LBlTIogcAiADwDQgAAwhiCQmkal0mWZIAxEFmMxiGFOsL+JDEMAFCgDFmggAFdQ5AV/+Ia0juOWkkChEwEYV0ZGwAlncA4pYgETwwCAQwYRBH9iiURBPgEx/oCCIIAIQDcGQp2CdI0nAPBDAHJgkB8EoA8DwUYAFBCkHcSiAlkQgk4K8UVkUuQxOgTAAz3QsFx2gYwwct5A0hCARv+Ij36uCEAaDAIG9gFgQbMkIyvH4JILKEAVt7QLKbwmADlSJBmIygArfvHLinwADynoSLw2cc0f6UEsgQNAYcTSxIHAQCzfykF+BhAACgyEZFfMT6iyWZB1eWIgcQiAKTxSAwIkQhT14IJcjhEPWwjAEH5wgBVwIJZRCEAUh0jBj5KZTAUEgAhcGsggAhCHhvGHAKSSQJZcANFkBKBJBuFGAJYBADbqYCEoEoAN3lWHABwjcSWFThDE0gMBjMEHgOACJMbAucgAoBjrMk8qAlAGiugkCOVoggASphGeycEQHMKPOvIzScdQgyApCIAU9JMfJlByILXEpyMC4JWBWKb/UwVZmg+x8wCLHCEY1ICEtN4AhytowBeWEEA6WOCUQ0RAAPSQBowWkQpHhkgD72hCogRgix/UAgY3fd8NAuAMKw3Eq4HJUC+viED/KaEg2FHHuvixkEdoQB3BeBcAfAAcHgTgDQvhqATY4sHnfEAANxDoHZaABku44Q6/EAAJdGIa3cXADOnL00KUcYbPYYEIjpnDRnIxHjTwNRJj489/xBLgVQ2EHU49rNnEsgGDBeARA/GLvwYC3CX00WySC4BgIWICMHjuFNa4RpICYAd3GMC2eUBXNrrQC5CIIVsCIMMFCqETUnSIICxogwQE8I4qMiFa5MBQQWzUBR6kwRpg/8JFHUqghuMggxqU4229sBCAJ0UJAA87hocs44aCfIMHULZpZAXQDAGcdiGiCIA12BWRXswipvUtyPoyqIsDoWAPOoEABcohAFP0ARdSwAIw0AxDFMmIIQIQhiYCgAEBqGILiYhGAMyUEcNMIACHAEA/AmCLhgbgJgHQROGasICBdK2aadue2bwRgGcMpNITHkgVcEUQ/TmgIFMIwDUWggRAM4Jkb4WyTpghj0H8KAZc0EnRKHYRFAxjHNL6xdJaQ4FRiKUTp5BWF+jgvz8LIAlXjAgLbKCDYDDjODxoRSAQeI5rAEEATgjBbqssJMPAJj8gkMIsLgEJg9jA3gs5wP/FJIIGddAAbRGRxTE/XEsj0WgDF+CJCf5gi0ao4hsGJ0guD7frfukkagMhRzczsp0m7UE+AAAOpzHRG8deAgBdCMAnTitQJw7EcvogiKcNvEWCPLABBUGMwAiCgpfrxI1tkETiSvYOnShg4BMRQDc0YD2IbEEnN1CEoMTyACUeJ3XHoYM5aKGHUoCC2zv5yAFsEI5eNJIEN8hgM0gA5R/cm0bbM6C+zdaBRsgCbCQBxDLYyZFYTOV9WayTZXBxaYP8LRcCGMRFnhAAfAAAEhdK26vZUHLVsIBQQ8wSW7CCQ+8N5PKY1WY7ApAJgjwM9gW5RxnEokQ68IYOvOK0RiL/cEqsE6QKAtgprBwpATcSBLwAaIMRPLEHV1RBxyYJAQpIhwZWwLEOwdc7dC6/NcOYIQBM6L5dFkix4gXgHLaQiAC8EAADxLois2oicBGQtmu8/mB3rY/jAgBmgviYSQCAMAgA8OoAWgCP8rCfgmAcbyAVeikIBdCJMsiAPkieNviIBcigZwMABBAFnQCFAAi7LDgfuwAEZ3ABAUgs1Si/APkO0huPo8o8F5wLV1CHqwsVDEAGikCEX0gMi8AqUzEG+QiB1hiI8uAbs2ENO4iFADiFgliBpRkwPCsIT/AqR4OGhdiprRGB6iIIBeCEP6AhkIiC6SiGLBCACaCOB9iV/+QDjSQwoYWrQefgj/lAIAGYpFWjQ7hYhmooLKixCDH4Qg0biPowggHbhIGogRIChoKABsoIAFIwCF5rEAsriA9oArHoFoPYAm3QA3g4ggDIhqWwDFTYEG7QCQlwE+ZIHA7gQ+cYmrnxKvjjPlh0CmMQgIu6iEsIgKFSpg+RlHQIC7cZiG/gqFckCEf4nN4jiBV4jFpZiBSYBC2EiHlogHaYhABQpVI8DlqDDiSggIi7ReWADUEwhCmoPHJsjsuDg1KaCNjAjjLQnD3MGn4yCEYYwIV4mACwh4hoAROJiKMSi7xbx4G7gACownX0jPzYgeVbSOXQxFCYCIX6EH4pwP8NmwgwiMCCAC5tILeM+Jz5Icep+0NEgMjOIESU/AzCykiDgBTDGgg1EAuF9AgBmIePcK+VJAgiXKqdvAsZKKyffA6xKDMAkAEZGAgdCAA6IAgYWAsafIu0GkqxOKKhrIs2eLSrbA6S+UYAMAI+4ANnAIB6CIBxMAgyuJqthAsc6o61lIstCIBzekvQmMmnGohaMIeeAYA0GhW6rAsoSB9y+kunWDBZIEzPsJxSIAie+RwA2KvwQcy5SCOykMymgACEsczNeKAPCcpcAAD/eQHFCEjNfIsTmKRFKc2kwCofUs27EIukJIaxmbnTABPXhAt3uoUZQQAC8CS4UcnbhIr/SuMJtwqZXBILyArOp3CHALjHk1CAAojOAoCApHioX3ybAasj5awL1LCOl+OnpQwAbyjG7WyKLWmClCCAAGiA6KROiUiA3owI+MSngSCA+KzP+ywI+Lw//cxPBGkQIChPupBNDBCPJWEBsZhEAW0KSHHJkVDPAiCIBHCABoDPAJiA13gA/2mAXwoABxBHAFgAOPJQ+BxRXyQAEyUA6wzRx8BQ9Ry2BuDPA9meMPDNBX0L1tAEwRELKrvRpVigBDMJ9XyMAQAABWDPBtC113AAC8XQ9bSK7YmoCAiABeCboaoABLBSAMBS69yeCH2oCoBQAtC0IkUQMyQEH5WLfHMw/wdN06Lgpgg9CfV8AKv4xSIJAP7kqdeIUD0dUiK9Uy5JAEAtgASwTvUs0kM9VABQVATZhsx007dYU4KAgP6CVKXoxUoqCQg1CAqAowfZUyO9UFD1QIgiCN5EgAoQxwEgAFRVVetEAFEtkgVQVEY9kHMIgKmzVKZYILxZwrvS1aO4vGcSUqL5UirVtKFazwJoAA4dVQDQtAdY1gFY1gJ4AA6lVmtVgBXVtGVlUloNgDI9ECqwRWA9irAQBOAsV5ToRXLtCASwCqtYgEJ9kHld0ggYAP4cAFQDw3hNAAS41wi4v38dgIBdVHz9F31lmHcdqoVNEF4YPHVdCunAhwC4g/+IXYonYCMBMMqj0NOdvIUCvVilwA4LWQ+RTQoCAIJWiJzq3NedDAAsOFml8J8AqAmZRYoXCIdcvdnXuBSeNYqiEqKfhYtTjZui1QxUGJGhLQqd4KKldYoEeAAmHYgEmE6IEMcAeAD6rIgIKICtHQgIkE6vNYkq3dfolE8HeAAbtQtUmKKnfdsZeSh8ggA4ilODoFNxZD2KUIBhu06C4BsHiM6vHQjerE8ZHQgF+CX4XNuHKtP8YNWCgNVwvYtA0Ee4vdwAaQAMHYgF4FZ4bFODeFf/8du9cRDSXVQPFYsJIJkYBYCHGrYBgCMlJYjGbZgJJRqCmIChywx54CrM/d3/5kBIl0Vdu12IItlcwoXX09VSg1DCrLVRMfWfBajdh4IAgHmAVPXFgngoohkPTXsQviGIIhncuQCB2wBe9FUOy/HbTYUIFJ1aMJTO4S3d01VcVS0IRQ1fRV1RnlpR2uUSqzCM8AWAAUbd050LWtCA9F3gxAwA4qpPj51ezg3UjGDehpXXBBDHT4XgItVfcHVd7e1f7f1fxx0Pcby/AgaYA5YLdvBJBn5hvNCNSWXdsfVgollhCVxWD6VORSUa+OVgAh6P/Q1hY/Xb2s2Q6x22SQXduGiDgoRhKK4L3fWk6YXX+5Pgd4XXg6WILI5XD1xVI+3X0AVjLAZjFb0/fTXY/8NV0V+0ivrUVwqlWs2NYjqmQwRogIhqFAKIVv9xT909XLtogbusY0KGigoYAPKdkQS4V0RG3AF44KKogZ21iGNAhUK+ZChGhDeAMipQs2LJhTnEZFH+3WEQwQAIgy4QgIeUCHfRqFF+5csVgeHTiZebAlaciPUBAVjeZcw9gHsgBJ2yiH3wWF4u5qVNAE08g4oQv5o0Zme+WcLShFuGiO1xpWe+5pu1jF1JTYjAn5jFZnAWWQGopVuAsYUwBiUIpXBeZ3VNvKKhAoO4hz88hdRjZ3vWVcsIg1ogiF7ABE0QgOm7Z4F2U8sogbQCDmUeaIWG1AbRZW1aaIguz0iABf91cKMAgIWIzugFFRslCmaN/mjlVMOXAziQLmnXRIB7EACONGmWbmmXfmmYjmmZnmmarmmbvmmczmmd3mme7mmf/mmgDmqhHmqiLmqjPmqkTmqlXmqmbmqnfmqojmqpnmqqrmqrvmqszmqt3mqu7mqv/mqwDmuxHmuyLmuzPmu0Tmu1Xmu2bmu3fmu4jmu5nmu6rmu7vmu8zmu93mu+7mu//mvADmzBHmzCLmzDPmzETmzFXmzGbmzHfmzIjmzJnmzKrmzLvmzMzmzN3mzO7mzP/mzQDm3RHm3SLm3TPm3UTm3VXm3Wbm3Xfm3Yjm3Znm3arm3bvm3czm3d3m3e7m3/3/5t4C5m3rRP+6yIC2CAILUABhi5jeAAA7gAiDAAA3gKCTAACTCICzCAZPyI7C4BCMsMC/AxAYDugeju755t7n2MZpUIAxCL/7CMdiVE54Zu+CYI6X6K+i6I7N7ujoCPAAhSqgCPSCWakAWAgq7t17VPkinehWhvsaBvAZeIdDXwCL+IDUDu88ZuBiBvirjwBMtvirgADtc5ADcIyyhwAPDw7wZxAEDuEr/wES/vDf+IDHABBggjDo+PEn/th4pTzETe6J6OAMiADajv9l4Vy5luBxcLBmhvAYgeADhyy3mM6TYMvUjG6BmXz5mO6y4IC4gesVDgtKnvDeCZMKfw//Bobw+4cPhr8SEH8xIob+oQ8uk2iPjg8IEUCxsnmionmi4PWiEPjwsAc/jLcADIbulO9Of+3CA9KhSH7YdiT5L54SCXAOrgACP/bzef7qAVufbWgPs+cgtobwMQgOs2DITMAADQHwWWDg9ggKISc8YED1gfVtiobwzwmlpHc73QAAhLcjfXAA7AcQCIDwxgAMuoc1ybDoJIdeTG9FGvxevGABVAdmbXnwCw8cYEgOix8fZ2AexW9ESP8YKIdf0ectqO9Ois24k48qCNnjTXdGAXnCO3b00HcdiIngs4qlfkGUgTAB0vCJ7JAAxwge++dQGnDua2DDAnb2Cfdyn3Gv+da/OCmPdDF4tS//AKtwAXwAAHp/BkhO9U14lcV3aOuADqyNQJiu0ep1omZ29NN3MBr/d5z496H4h6x/cP4ffomQ81V/QRz+7H8PUxF/A7CvNsn/jphvj/nneLV/pTmXMBz28L0AANKAHHzG/4thxQT3T+PnRxl25yBwBL14Auzzn01lOACQARv2+DqPcNmPN4B/eiqvMHw3lNx/tVsYzthg3WiI9hvfLKYW4V2IALD/gHB4BcD48sHwgtZxeun4+Hp/gjZw22J3uKb3Z0HwjlPvRkB/nIinDDkA4iV3zwYA0NiJoNUHmwD3tyDyMbn3HOZ/a0717qnPIGz3vpmPr/7q3z+MiAV7/5KNf0oDWAOM8PM+/yuB9yAwh4e5fu6YCwJXdvANh9A4Dy+taLZ5r8Oq/3MKLyhVD4ic+A5hfw4i+B4medgSB06v8c6Dd5jJhyPieIoorz2VZRLcYnC1C8cgcIARYAEHQhgAGADQIMYLggQALBCxgMGLAgQSBBABcHAnBBUQAAASAjityQcYNHAyVcmMzIYKIBDi0tTDx4kOBLii4AMLipUMAFCw8BCIWoESNPAS4kBDCQMSOGACNRUiyhImNKkBIYOhx5VAIHqThhckD49CzajEJFsjUKwEAAt2nn0q1r9y7evHr38u3r9y/gwIIHEy5s+DDixIcX/wrgoCEuWgsaNFwQXKKEgKgBOCp+qiKAh86iR5Mubfo06tSqV7MuLCFDgAAZvJ5l6qHlX8exPVwtfWFy5dbChxMvbvw48uTKlzNv7vw59OjSp1Ovbv069uzat3Pv7v07+PDix5Mvb/48+AQEEKBv7/49/PiCE0xoEKDBhLwEBrAnEGCAfAEKOCCB5jkQQAQERNBAXQoQkAAAAwRAQFoEKIDWegVquCGHHbIW2wLsQVhAAASRCIACD8SG4IoF+AegAvYF4ACEATwgYwUe6rgjjz3yBcGKDywAwIlElkjihQlOgKCD/wHgQAPqBQABADZWEEEABfi4JZdd7kgABAcGoP9AkSdm+ZSEFL5YpZZsuvmml3HKOed5A0D45JhIJnAgAA88AKECCKQJwJp+AoBAAPmdCSedjTr6qHWxFXBgfhLGZh8AC9hIIgGaPjDBmpo6cOOFiy4KKaqpqnocAgsMMMCFBLmqgKsEIRDBAENmOkAFglKI4gARsBehrrmu+l4hYMBwLLN9nfDBERt88OwGCSSwAgoIMIDIILw880EHzYpLGAOxEnTAKIyoIUAWgc0ggA7kPUHOH3YpINI4WuwlhEiPdCCCDAdQw8Z3JqQgiByN2MIvPGwJIcQ3VIiSCL9sWSxSxRZPEcQpEASxMQSEEMLBDRMU4IUBt4ATBAiZjJv/F76y2HCMDUMggMAHG4zwgkEisZMCXyE4kYkWw1x89B5k2CKSMwKkk8kPVCSRSSbyQKLKPCJRrMoFvBSyhT0EPOMJA0NE4YknvFQBCAsbCJICGGYoY8EKTjhhwTGCCLKBGDXosAMLLdTgRD2vqKCDBYLciRY5BZTxFBuxXRGAFUcL0IgWP8RDzSD1/JEML49sQU0bM0iYBrxmQIECGICkkIMgNkSSgzJGrMMJFWf8IEsSsUgQDBU/VJDFMpDUw8zVFu+RTjoiFSPEGEJk7XALdmUhQDGRoLDCCDWgMIIYOwhwySJ9CBAOF0Yg0wsZkLBVRmzTUCLSWUe7AogAOMTG/w0IcfAhwDXQIQA5IGEHdDlARkQQAxa8gAXfq0ENWuAII/wgEimogQhEkIIqKKB6T/mJ5UTSPAEkohhs2cMrBDCGMTAjAmwxRRO2sQkp4EJ/7VgRDnAAjDBo4Ao4sEMnHnAOa3hDGneIjf4C4AZrEKEMllgDE2igBDQwoglNsMQ2aICBX5BAACDoAQ1wwYmX3eUD8ZsFD+jBgzlMYAJBgIASgCCjAGCjCSG8Iwma4Q1KKGJFsgGGLjSxIj18ARexYUUAsuGNOoSBCd7whjvcgAVtSA4HWKDALUZBBH3AARy0KMAcVkELWtwCFGjoAgS20QRGpEIYGOBAM5qBAXpsY/8bEPjFG9JgiC5M4g3N8AUsPJAGDGyDEGiRhQAWERsWZEQeU0qEAHowijD4MQBSoEQdpHENA/iiD2u4BTeIcA06FEGZmAhAGlLRgxswAg1NoME2eBAKGgjDHNHIQBg0UYdZMMEPD7BGGOrgACuoww2+sIMkA6CL2OghG9mIDSpwcAccUBKHJCBICKowPYtZIQCoCMUNOKCEN9xACb8wRABWIQBLBKAVljDHOQLxBTcMki0giM0yRBILAVQzAKVAQwCaIZJ3pKEEFKDEHKoRgE3swhB3tFgc8tAFIHShpG94wySgYY46hKIJb4hDHJoAijJMgjZAokABOuEAazgACyv/emgAroCKQcIiAHe4gx26wVAemGISRXjqxZhBCgkgIxiZiMcYLgaJYGxBAVxIRhJyMAJAgCEFKeCCIHJgATGEAAAdgEIObHGMCv0KPQQoLWo+YFMSkKAHS3gtOMRxiW1YbBcY0AcFlnAJK4QhA17wwixkeg4mnOMTTGjCX4/GiW9I4gyAvRgIngvYKZziBqfoQRDQQYdUkMwQIyupEoIgXj7wAQh5AMLRgBGADzyFBbPQgwCWBIWMSIISLYFCIajw1CLwQQ3rYksRknsPAQThEtyohgGaMIUbmIIHu4BAF/93sV1IVxLSZUsANACAQ5AAFBWNjR8s8cJdgKIUNDiF/zlKQAgBRAEAXBAADXpAiCAgLSMdIJE6QByAMoTQCQQ5hA5qcQEtDMEYAoBGE0rgx3P4gRu3KIA4xAEKfazhDTzoAwXQcAMGK2HGAsgDByhggE00oYuxQUFGYnMBBpCiAsGogCoujDQbmKAFM4AOloaEABLNyFwJKEABzFUXCAAa0FQiyJ8DjRgyHZrQgn6KpiIgnA6EIARQ8AGmn0GMJwjiKUiwgD0u4IMnZIEKnEAEImTBPmQkARkLSEIK7hwYBBIkXIE5wRFQcAQofIANbTADtnZwre+N4APGloEMXhCDF6AFfp3OCCkCgA9CBQBoBLGAvvQyAxnAYFkZmYGsCf/ygSc8whiDSMEJUGACGyBhAyE4gAzQgoTExAYA7wiAUy0WCy5kxARIqIIrcnAEI9RicQTJARQSwN66jCE2IoGAAB6dF0ekoBYWQ0YsHsELBhCDGFWwRzJqYIM/XAAQKFD3CBQOgBis4AKDkEMKOvuLANyAIIIIQB8ClIAGUIAgBCjAAEjUcxPFBrV0IXQBVNQmI01oLhlCgNGh7vNhZcQ/beKUrYxeH4OTUTGJCEAtnrKKAHTWCAHAA3zqHRsDnkYIKSUIbpgjhtiYJA4BKESAsER1glQgUQRZkIqMbhcV6QrwTX8KiQ7UAEtRyT9imoDi9251olNIUysC0KEQ1PX/0UQhAMh4CuUIooUAPNs9sXEEaFKzhwDYYjpRaf0XAsBM+VDgAWch0QPYg4AGRADrGRHUqwTvKVvx3vcZIZGrskQAFVHbRYSXEOZ93tP12EhK0X/A0DevmB0EYA30G0EAgEAQPARADPB5DDwCQIbUyIEH5peODQJgjSqVKECAPosC+u4AAFBg8SqaANWRCaDpylMQHkH03wD8396dyJowoJM4YPRR2wO8SuCtyZqYyNJpX2LwVL2ZHTGMXwCAAXxIQwD4QgB4EGrYAHWEgNphgoBMStVdiALUG9LZhwNIXFpgie0RRA32GeKVSAMC4QMKYQROnpFYiN9d4JNkoAYi/wYoxMYHUMF6EUQVBADBvAcdrEiXxIYI+F2ASMidWEpsHBrl4cXOBQABHt/hqSG1AQgEGkkbPoURYt2BFIB9YF4COEkTKkYVzJwnqEH9AUAViuB7AIEWcklszF0vCAii4KGrDIDRucre0YUCBEtaSOJZ1Iqv7MqhQCInbuLvGcuuiAiuYImkRUgATOIeGsbcrUGRuFgAeMKhtAt6iEJslECX2EEAOEEAIMKAAAkOckeh3Qd7xAgZrmJi8MEhEkUAxAMASIIVtMcMGkDYcQkcBAADBIARDEgCWKJ47Eeu3AmucB0yGoYMnEO9EUQLBEAwAAANBOJ5CMAgeAk9BAA5BP9AJJSjPo6H3QWiCQRAEgAAEcDjPioHPgTAHFRbQS5kd/RdIHYhPwDAQzHkcsygirAdRWZkdXQePAbAIqajRhpHB6wImoWkSULHM4BklVQC/Z2kcayICbikTC7HEahkANwCABzRTA7HYxDkTv6kcNhkiegkUK5GQvpkUSblaRRBHoBeiaikUpbGH8hfVFblacxADDhlS1plaYiAALQjV4alaQjSVoqlWZ4ldizJBkAlWralWzLHIGgjW74lXdalcLxAAKjCXNolX/ZlaQQABeylXw4mYRZGALRDNCBlYS4mY/ZFbPCAYjamZE7mXMxCABRBZFKmZlKmKdBcZm4maC7/pn90QgDEZGie5mTmYSKiJms2pgkGADm2pmzWZSUI5mze5lnG32fiJm9aZWzIQW8GJ1rGBg0Ip3GG5SUk0nEuZ1SSgW0yJ3RmJDU8Z3RW5z6a0W5ap3auIhNk53Z+5+YlAW2AJ3mWp3meJ3qmp3quJ3u2p3u+J3yWh4UMxmn5hXoEo4ZshVxwh36CR39+x392R4C6xwIUWqExil/k2V8sCX4SCE8JAK11x4OCx4RG6HZMqHdg6HsUqOLdH1oowIWox+LcJ1rsXPYRyoNUndHVJ0E8ABNyyINa6IWKxXdUaIbSqITiKHwYoZtIiJgMgA3KiozQyFPonc/NkYWoyH1c/8gCyAiDZMqY7IiG5uh4zmiVQoeMPsWU5oWtKceWSkeW8gWPnomEQEDfPUAFBOaDACYAKGhG1J4aUkivjEoCzOAE7NyfJMChIcopesiXasefrkaY9kWgGsagAsYBdGn96CiXMkehOseh6sepkGnTUeppVVMEeiiUSopqtogSplkEHgf93AVF5MWA0sWjEsSpzsWqpkWrokWp3kWqqqoBuMWgviqsOgUARGqs2sWWhmmv1sWAJqqr1updBCixpsWsvoWu2gWuPkWw0sWzEsSyRqu0GquzYmtfROpdjKmWDIqlIkr2LeD+TV2a/oef3MnNsCkA5AgA5GGovmR2Uie10v+ooqLFrC6rvjLqXEBlmO6rVwzqspZlRmQpvf7qvRIsquposi7qlTosXizrwfJrWkzsw2opxR6AhdJrSFAsxPoFt9qFt6IihVgqACyJiy4emsCmiTRA0jUArdxH0mnJkjgAn7TrGiKHSiYsQfjrXGAoz2ZEvnrsxz5FlkosQf4r0Ubon1rowLJlw/ZsdiIsWlhsxEoFtwIsXljtXeylxgot0YLtlR6At0ktXhzA0F7saAgKARrLfrCH2/IHQVRiOD5FI9pKKQ7LrQTLsNDtryQdczgcW/zX0Qjuc8GFAUgX4h5uUyhu4zJu4j6X4T7V4kKu5UrX5NrUxWRuCFUuYHH/ruV4LuU+7uhGLmCJ7h2B7tGgbgipLghEl0iw7uqS7sUQLgdemOxeTO5azH42BzD+haa4q3L0ZE8Vr/EeL/Imr/IuL/M2r/M+L/RGr/ROL/VWr/VeL/Zmr/Zib7M+Rzf26V58b3NcxIXBrpydL/qmr+WYr/q2r/seDfu+Lvu+L/3KGQiQwOvWL/rOr/72r//+LwD37k5qLLciUMgW7Nne6wEbbYRG7a7yxdeei14QMKJGsGd1gAVP8AEfwLtF6gLvagfXRQZPMF0ErV18cHzO2gPnRQHvqoyisAsXrAJDcANrMAyL8AhjaQgf0HHccAoXhwG/8KwJ8V5YsA8XBgX//3AKj/ARK7ETPzEUR7EUTzEVV7EVXzEWZ7EVQ11sarEXF4YAGtppDMoXl/Fh+IfLFsAxlmiKpgWJqujinBY5qsckiqgZ33G3nsqeRIl/KIqfLGmVOEBgZsqQqgeSEgCSDorlJeGMXIoqhqYZnIUoCEBJZoQyCIAv4nFr+MfloYjLNkC5zoiUKMri2Qmb5hnW9UoqC8qE5OG3BkAFWB0BLEm8gqYApIJXPMJj3AA1ZMQZCEMAeMH6afJq+McEeuKmDoupaMmicPLlLXIBJAA0d+OEWOB/WHMtayYHliZBcEMAUEIAXIMriIQg8dQXXE68EfNp8OgB2scpnomdvom4/v/eepwrJCKAPacJouSHpiwANrMmIIAGZLoM/WnBvZVCbNABSAhAH1gTHzwBnSjACADGERxBqjyBSMCDCnTWCQyBYDgzpS7AkpTsJ8MsnKCsHQady5KKHb5sJTbdktghjfwzakaFCsSfJbxrALDChllMG2TEH4hEAFyCCetI1pSBEuBDZ+2FxZ3CKVjOI5gmAKyASKjARB/QE0gCOySDBZiBBQxBuGnpxVSyaqAgAAhCMCxAOgOAI3hCOBhD9YABIrBFch6mB3TRFMyBSFRjXwDfqyyA+IrvjODKsIji3P51AuytsBxK3hKK3LZr3W4iKJ5mXfVsNwDAFgSAKeBFPYL/wHQQwzAAQlm3QBZQkgnmw0XlxREIgJJhQR/1FDeYAluEBWgoQb2kRcNcgi5gwxpgQCpgwBwkl0jgnS1WU82FhEiIAmEoAylsgQgAAAt8wFIDwAsIQFmJgUhsgzV8goQdGS20QjWUFSN4gR9lRmzAgSZYwSgcERqMxqlA8QEEgB6YLfz4AF4cQ2ysdXN4pTgoAhqo7VO4QjpItV80wiRMQkcJQD1woH6jRTiwxSmUoACogtEcTR54wRdgARZgw4qxVB/0wsIJ7Q2lgRJI1SQoAQ3AwS2EgV4FwCgIwGNYzNgJNWxogCzuhRYcjTB0AhHEgQB0QRB00RPEgCEK0sx9/8Em3AAQfMKKbEIe/DiUgIKPswUApEAA0AIBnEEWFEJiCcFoGHaq7IAJ/bSX8OIaSK0A1FVW4oU+BIAyQEdtmoMAJCYz2IsAlEI2bPZfIIEUBAAcuIEhZASQ8MFc3Esr+NE71ENdxAAikIEqqAI7QMiLBUAg0NjlZAJPsQK8jMACtcAI5AAB8AIVuJB1w8In0EYU3EJspAEn8BQtxMtcyIAKsEUOCAA4+5EmhMKPj0I01IEwXOMl5EEAlIBzKTQZyAEKvMACsIUcZCULVIALVMFzP4UIlMGNi6UhzBUdPEN0nMATNMK1q4YUygJBkEBszEKg50U2UgFe9IJIkIJqsP9APmgjAKxDANhBXYAB/GBA7NVAXbAAFITpOAw7AUACRm5AHWAjAEDCGJiQSMCP+bDFIQCGSKCjNXnDUjlDXrTAK6QhQfCCIRQBrPNUGrzfWXABH3hAAORCALyjIlzMGeQjCxTCOvyAMhCAACDSKlRjGzQxitQF1D1yewS9c/BCABABT4FDFSzHAbBACDiCAEzBJUgBLQjAVesFF3CCEeiAv/sFMHd9CIiELGDkXcyAi9uFCQhAIMRGJ6hGFwRAD6RZZjJCACiBBQAJcP5sF/SAAHj0Wcw7Xz+FvReAALjBHcxVbMCCANx2YSDDxeS9YOxAWPPUL6QFSyl0JaiBH/z/wjDoRdO0WGkkwAMQ6QKoiJDgn4GucV30nsQpgOKp/mAUqK5o6lnsyZ80h6pvQceCAqwPRiyIwh4kgZFZjEXfxRawRReQADTEBt+/oxIYkBlYTBa4gn4JgCgYgw2IhCVkgDmkwRuM6l641WA8pxS2ggCMQiqmRmzMF0FQE7OlRTwEQDVMdFy+wlw0wqoj5Fnc44kCBACBAGIEMKhHwBQBC18NdPgQYkSJEylWhMgjwDIkMP6Y0SIggIM2AmHEEmMRZUqVAgcEUAAAQYAHBB4EQOCQQIAGBQpAQKnAgUECEGtWoBBgQUQEQwEQuOlQwcsEBBI8bDlAoMGBTh3GxLoS/+zDHOwqqSIQ7xhEEQO1CpwUIA2MsA//CPCjQQ+Tagb5nhKA7xAYPICU5dBBbUg9AUQMfjEArgAfAVAA5ABp6F4qg6UCWCkVxqCGahinwSE0Z9MSHAEEqJhBcYSrYB0AtJ3LNsABijXDAcgSYMztuXgCwHHIKEAjgVUWVlpQSVoAYwIdBfAS8ZkU1jpsA5CxKMCFiYQM7jlwQnh69RFt6FK3S02fVJQC0KqwHj/KBhMERgjgE4IAIsApJK5QQmCAmpgaSIGQAKggAAoIDCqACYJq4KaWKBygAQcduiqrAABIgELbJmggP4sEoAGbXLCAQxp6WkMgiYXiEOCVegLwY/+gFpQIQA3hTBCgjwC2WQgCdBZakrN83mGkHDSEoSGNa+bwJQA0FiJjkGcYkOEhEgLAJIBUBHBFgBsgWFIANYoQYByqhpDDByGgCcCDN1+JJSIlSrFGktpEVM+bAKqS6IC2WgjgkxQtElMWh4zwEBSDcvkklwDiGKigQR0aApwAihBIkQC42CqAPihKYCFHXb1NEgHogQMdHkIRwJNXdQXgAqRYCgArEFHla8CBEBxggAUHKiAAZZsKoIBno0W1AJqQArElCCB8wKhmP+SLLwAmEBAAZgdawKVdH6LjDTbR4QbPCZgIoB13AoAFS1IcGsGLACJV6QREBBjAlACuEED/EIE2YOMhVwYQQBhhCOlCgDj4uHEhQCwKQQCKzRgIhQ0cguG1iBxZqIx7/RDgpYFWCECTAOyoTZ31OAngPol63WSgotR9qF+GHdJqnAC8YXOAtQaqIwAbHpojAD5KTue/gd4JoJCftVbvGALYsCGSrR1lwFsAsAXWoQRuyslTABTgqYCkHmLW2ZyitZtArMzNKVhvoTW77F8LQFYrc8v1NCdnd22jBgB0A4CNRwQAYUl45GETPYcQ0WWWrFGSYYp+A3ADhERSUkaZBFgAQAQZRHhcpdXVU2ChO8sIYSBSgO3XhNHXi6mEiY6KYiAJPNw6U4iCGmOabjKh6IcAeBjZ/yAwBWojgEAGwiIA2cX+HvzwHyI7ZwglPOq+BbAi4KWcUEyJboEQpEonAPzzCVW9ReQb8KH+bklZwtLKUW5iuAcFTnwC6QDsLCKJO4xCALSpCB8CUIKFQEKCCcSPI8hDgoGEIgA1IEcAfjM99YSgfhEZgUFe4BDODGJrLOiOQCB0B3JV5AoBqMdAChEAfThkBraZoQaJWMT8VE0gQWGWAwRirpbwRW4VeVuHHOAT/gXIAQ3AUN4O96y++S9aAPzWV7SyLQoNJEBGnMsYikS5hewhIscwSC3UmKIElCpndhCRDfAUgDPgZ14tC1MA5tCwABhga48IQDkiQoImCAAlif8IgC8+IBA4BOB5DukQburYSU+u5ESHSoD6FnAo9Y1IfQMQZEWOhaykzI+GA4jAU4yVLACcEpYEGECGkqJLWjbFlmb7ii4XkEWBJGA/n1RJXaIxugAgpAoOQQE9ApAHZa5nGCFxgqAEUgSDPAE/2SwDRHTQABwMASKr4YXWkKODiIQgBSrRTLFWs4KHaIZP3LzmPvmJgAZIiJ+uokkBaoK/E/0yoBJZhwAgIYCjgEIAnBABEm4QACDEIKG3AUkzyDaoIAbAnus5wLxONRAzpCEAQoiIEAJwi8ztSo8vFY4ZAvCFEEGkQTxKVC4y2lM1VkCVPl1PAiKArJYpYAA5Eyr/RS4ggFNMIwNx2EUAltDCpa6EA9CK0ECmgIYUJSEAlnCIZjgwEUv4ET8rcMEwIDLE23SINm4FRgAQkah2XBWvedXrXityhHEI4BZhSIUP+GqRFQiAEJMQj0BOoLEUnYI1AmFGTUMaES5kDz8caIAiejEQY4DkHPm5Ex5qc4eIfMM6tdFFYVnbWtcmlBdU+NhrJ5KAFvzsCCiVhA/soA0yVGSuYFAPGAKAAxwEQgcL2YsdkJEf4lgCBp2RyCUVeQXaXhe72dXudgeiAzfoYgkBmIdFXhEADKgHOUJoCUqvgAEBMCNFiQrAohghkZzACwvc1e9++dvfa0KCBqWApEVe/+BWldwjALgAABJScY43JMICr7rkGQJQiYkw5m/+1fCGOdxhR+XAFSrRRwB+exsy2UIgZkBG43SVEysEoDcS2YJBmuBhG98YxzkWjj1qepuCLAJ8nTAICihikIboGMlJVrKO6ZOEuUxKGOAjRasoIgA6bHPJWdbylrerhQAwAXdgmUIAQnzNkXAZzWlWc14pSAJqgGVeQlvznOlcZy7LAB0BuAY+VmJgO/8Z0IHmLxsEMIt8DNgiNQiABgTdaEc/OruysEZkLRKPAEQZ0pnW9KaFGoxWsCbCFMnqdDhdalOf2ojheAsGLDwRVgSgZKiW9axp/aoWCEAKuWDTQsIGgHwVtq3WwRb2sFXSiCB0IwB3iFkAbiWAH3mV2NGW9rQH8oEICGAMZ1gIvAIgjR44ltrhFjexJSeAeFBm3OlW97rZ3W53vxve8Zb3vOldb3vfG9/51ve++d1vf/8b4AEX+MAJXnCDHxzhCVf4whnecIc/HOIRl/jEKV7x/gYEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sample tracing of an infant (30 week gestation) at 43 days of life (36.1 week postmenstrual age) when taking 4 oral feedings per day: A) nonnutritive sucking on a pacifier for 3 minutes prior to (B) nutritive sucking from a bottle. Scale rating in parentheses based on the sucking stage scale.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lau, C, Kusnierczyk, I. Quantitative evaluation of infant's nonnutritive and nutritive sucking. Dysphagia 2001; 16:58. Copyright &copy;2001 Springer.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27184=[""].join("\n");
var outline_f26_35_27184=null;
var title_f26_35_27185="Proctocolectomy for cancer and division of lateral ligaments";
var content_f26_35_27185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F84656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F84656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Proctocolectomy for cancer and division of lateral ligaments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27185=[""].join("\n");
var outline_f26_35_27185=null;
var title_f26_35_27186="Paraovarian cyst";
var content_f26_35_27186=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Paraovarian cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal ultrasound image of the left adnexa showing a paraovarian cyst. An anechoic structure is noted in the left adnexa separate from the left ovary. The cyst has a thin wall, as indicated by the arrow, with no identifiable ovarian tissue surrounding the cyst.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Thomas D Shipp, MD. Copyright &copy; Thomas D Shipp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27186=[""].join("\n");
var outline_f26_35_27186=null;
var title_f26_35_27187="Optic pathway glioma";
var content_f26_35_27187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F55797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F55797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Contrast-enhanced magnetic resonance imaging study of the brain showing an optic pathway glioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 469px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 2 1/2 year old boy was seen in the ER after a closed head injury. Although there were no external signs of injury, a CT was performed because of a questionable loss of consciousness. When the CT was abnormal, a contrast enhanced MR was performed. On coronal imaging (A), the optic chiasm is enlarged and enhancing (arrow). On sagittal images (B), the lesion can be seen extending up into the hypothalamus (arrow). A loss of vision could not be appreciated by physical examination. Biopsy was performed and revealed a juvenile pilocytic astrocytoma. The patient has been followed closely with observation; tumor size has remained stable over the last seven years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lawrence D Recht, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27187=[""].join("\n");
var outline_f26_35_27187=null;
var title_f26_35_27188="Neck pain";
var content_f26_35_27188=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Neck pain (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?26/35/27188/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27188/contributors\" id=\"au6980\">",
"       Zacharia Isaac, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27188/contributors\" id=\"au2088\">",
"       Katherine L Dec, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?26/35/27188/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27188/contributors\" id=\"se1340\">",
"       Steven J Atlas, MD, MPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?26/35/27188/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27188/contributors\" id=\"de8761\">",
"       Fenny H Lin, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?26/35/27188?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      NECK PAIN OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Neck pain can be caused by a number of factors, including muscle strain, ligament sprains, arthritis, or a \"pinched\" nerve. Approximately 10 percent of adults have neck pain at any one time. The majority of patients, regardless of the cause of pain, recover with conservative therapy.",
"    </p>",
"    <p>",
"     This topic review discusses the causes, evaluation, and available treatments for the most common types of neck pain.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      NECK ANATOMY",
"     </span>",
"    </p>",
"    <p>",
"     The neck, or cervical spine, is formed by seven square-shaped bones (cervical vertebrae), which are stacked one on top of another. The vertebrae are named for their position in the neck, beginning at the top with C1, C2, C3, down to C7. Together with the supporting ligaments and the overlying long neck muscles, the cervical vertebrae form a strong spinal canal that surrounds and protects the spinal cord (",
"     <a class=\"graphic graphic_figure graphicRef69175 \" href=\"UTD.htm?6/4/6210\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Between the neck bones are discs, which function as shock absorbers, cushioning one bone from another. Applying excessive pressure to the disc causes the inner gelatin-like material to protrude through its outer capsule; this is called a herniated disc. (See",
"     <a class=\"local\" href=\"#H12\">",
"      'Cervical radiculopathy'",
"     </a>",
"     below.) Other variations of disc injury include \"bulging,\" \"protruding,\" or \"rupture.\"",
"    </p>",
"    <p>",
"     Directly over the bones and the discs is a dense layer of taut ligaments. These thick tissues are attached directly to the bones and function to limit the movement of one cervical vertebra against the other. Car accidents and injuries to the head or body can cause injury to these ligaments. This whiplash movement of the neck can range in severity from minor bruising to complete tear and separation of ligament from the bone.",
"    </p>",
"    <p>",
"     After the small muscles between the vertebrae, the major muscles of the neck form the next protective layer (",
"     <a class=\"graphic graphic_figure graphicRef63871 \" href=\"UTD.htm?2/14/2275\">",
"      figure 2",
"     </a>",
"     ). These muscles are responsible for holding the head up, maintaining normal posture, and supporting and moving the neck. Overuse and irritation of these muscles is called neck strain or neck tension.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      NECK PAIN CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     There are several possible causes of neck pain, although it is often difficult to know with certainty what is causing pain. This is because the examination, and even imaging tests, are not able to easily differentiate among the various causes.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Cervical strain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical muscle strain can occur when there is an injury to the muscles of the neck, causing spasm of the cervical and upper back muscles. Cervical strain may result from the physical stresses of everyday life, including poor posture, muscle tension from psychologic stress, or poor sleeping habits. Typically, symptoms include pain, stiffness, and tightness in the upper back or shoulder, which may last for up to six weeks.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Cervical spondylosis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical spondylosis is a condition caused by abnormal wear and tear (called degenerative changes) of the cervical spine. Wear-and-tear causes gradual narrowing of the disc space, a loss of the normal square-shaped bone, and growth of the edges of the bone (bone spurs). These spurs can increase pressure on the surrounding tissues. Up to 90 percent of pinched nerves in the neck are caused by bone spurs. Some degree of wear and tear is normal with aging, although severe degenerative changes are not normal.",
"    </p>",
"    <p>",
"     Symptoms of cervical spondylosis can include neck pain or weakness, numbness or abnormal sensations of the arms or shoulders, headaches, or limited ability to move the neck.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Cervical discogenic pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical discogenic pain may be the most common cause of neck pain. It is caused by changes in the structure of one or more of the cervical intervertebral discs. Common symptoms of discogenic pain include pain in the neck when turning or tilting the head. Pain may be worsened when the neck is held in one position for prolonged periods, such as occurs with driving, reading, or working at a computer. There is often associated muscle tightness and spasms. Discogenic pain can also refer pain or odd sensations into the arm or shoulder.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Cervical facet syndrome",
"     </span>",
"     &nbsp;&mdash;&nbsp;The facet joint, which is located on the left and right side of the vertebrae, is the most commonly affected area in whiplash-related neck pain and headaches. Another potential cause of cervical facet syndrome includes a job that requires a person to repeatedly extend the neck (tilt the head backwards). Symptoms of cervical facet syndrome include pain in the middle or side of the neck; some people also notice pain in the shoulders, around the shoulder blades, at the base of the head, or in one arm.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Whiplash injury",
"     </span>",
"     &nbsp;&mdash;&nbsp;The cervical whiplash syndrome is caused by a traumatic event that causes an abrupt",
"     <span class=\"nowrap\">",
"      forward/backward",
"     </span>",
"     movement of the cervical spine. The most common cause of whiplash is a motor vehicle accident. Symptoms of whiplash include severe pain, spasm, and loss of range of motion in the neck.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Cervical myofascial pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Myofascial pain causes tight and tender areas of muscle that are sensitive to pressure. Myofascial pain in the neck can develop after trauma or with other medical conditions, such as psychologic stress, depression, or insomnia.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Diffuse skeletal hyperostosis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Diffuse skeletal hyperostosis (DISH) is a syndrome in which there are abnormal calcifications in the ligaments and tendons along the cervical spine, causing these tissues to become hardened. Many people with DISH have no symptoms while others develop stiffness, loss of mobility, and pain. This condition can also involve the thoracic (middle) and lumbar (lower) spine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Cervical spondylotic myelopathy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical spondylotic myelopathy occurs when there are degenerative changes that narrow the central (middle) spinal canal. This narrowing can injure the cervical spinal cord or cause it to function improperly. In addition to pain and loss of motion, signs of cervical spondylotic myelopathy may include a variety of neurological complaints. Weakness, difficulty walking or coordinating movement, inability to empty or control the bowels or bladder, and sexual dysfunction (eg, erectile dysfunction) may occur as a result of irritation of the spinal cord.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Cervical radiculopathy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical radiculopathy occurs when a nerve root is irritated by a protruding disc, arthritis of the spine, or a mass that compresses a nerve (eg, a synovial cyst). Signs of radiculopathy can include pain, weakness, or changes in sensation (eg, numbness, pins and needles) in the arms. The most common causes of cervical radiculopathy include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Degenerative changes related to aging or injury",
"      </li>",
"      <li>",
"       Herniation of a cervical disc",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      NECK PAIN TESTS",
"     </span>",
"    </p>",
"    <p>",
"     It is helpful to determine the cause of a person&rsquo;s neck pain. An evaluation with a healthcare provider is recommended for anyone with a severe head or neck injury, inability to control the bowels or bladder, severe pain, numbness or changes in sensation in the arms or legs, or if pain does not begin to improve after one week with treatment at home.",
"    </p>",
"    <p>",
"     The evaluation of neck pain usually begins by observing the person's ability to move the head to the left and right, forward and backward, and side to side. The healthcare provider will observe the posture and movement of the neck and shoulders. He or she will feel the muscles in the neck, head, upper back, and shoulders to detect areas of pain, weakness, or tension.",
"    </p>",
"    <p>",
"     In some cases, further testing, such as an x-ray, computed tomography scan (CT), magnetic resonance imaging (MRI), or electrodiagnostic testing (EMG or electromyography) will be recommended. The need for these tests depends upon the person's age, symptoms, medical history, and examination.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      NECK PAIN TREATMENTS",
"     </span>",
"    </p>",
"    <p>",
"     In most cases, neck pain can be treated conservatively with over-the-counter pain medications, ice, heat and massage, and strengthening",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     stretching exercises at home. If pain does not improve after a few weeks of conservative treatment, further evaluation is usually recommended.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Pain relief",
"     </span>",
"     &nbsp;&mdash;&nbsp;Acetaminophen (eg, Tylenol and others) or a nonsteroidal antiinflammatory medication (eg, ibuprofen, naproxen) may be helpful to relieve mild to moderate neck pain. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     For people with severe muscle spasm, a muscle relaxant may be recommended. Both tricyclic antidepressants and muscle relaxants can cause a person to feel sleepy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Ice",
"     </span>",
"     &nbsp;&mdash;&nbsp;For some people, ice can reduce the severity of neck pain. It can be applied directly to the sore area of the neck. Ice can be frozen in a paper cup, and then the upper edge of the cup can be torn away. The ice should be moved continuously in strokes on the neck muscles for five to seven minutes.",
"    </p>",
"    <p>",
"     To control sudden onset muscle tightness, place a bag of ice, bag of frozen peas, or a frozen towel wrapped in a dry towel, on the painful area. The ice should be left in place for 15 to 20 minutes to deeply penetrate the tissues; this can be repeated every two to four hours until symptoms improve.",
"    </p>",
"    <p>",
"     The skin can become injured with excessive use of ice, especially in those with poor skin sensation. The skin should be inspected with each ice application for changes in pigmentation (eg, lighter or darker colored skin) and any changes should be reported to a healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Heat",
"     </span>",
"     &nbsp;&mdash;&nbsp;Heat can help to reduce pain in the neck muscles. Moist heat can be applied for 10 to 15 minutes in a shower, hot bath, or with a moist towel warmed in a microwave. However, acute injuries should utilize ice as the initial treatment. Heat may be used initially for patients who have cold intolerance to ice.",
"    </p>",
"    <p>",
"     It is important to avoid overheating the towel and potentially injuring the skin, especially in people with poor skin sensation. The skin can become pigmented (discolored) in a blotchy pattern in people who use heat frequently.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Massage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Massage can be helpful for relieving muscle spasm and can be performed after heating or icing the neck. Massage can be done with the hands by applying pressure to both sides of the neck and the upper back muscles, or with an electric hand-held vibrator. The neck muscles should be relaxed during massage by supporting the head or lying down.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Stretching exercises",
"     </span>",
"     &nbsp;&mdash;&nbsp;The range of motion of the neck must be restored and preserved after an injury; this is done with exercises that stretch and strengthen the neck muscles. Range of motion exercises and stretching may help decrease pain from muscle injury.",
"    </p>",
"    <p>",
"     Exercises can be performed in the morning to relieve stiffness and again at night before going to bed. Expect mild, achy muscle pain; sharp or electric pain in the shoulder or arm is not normal and should be reported to a healthcare provider.",
"    </p>",
"    <p>",
"     Do not attempt to perform these exercises if you have a pinched nerve in the neck, especially if there is pain or numbness into the arm and hand, unless recommended by a healthcare provider. While these exercises can dramatically improve symptoms of a pinched nerve, they can actually make the problem worse if performed improperly.",
"    </p>",
"    <p>",
"     The most useful stretching exercises for the neck include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Neck bending &mdash; Tilt the head forward and try to touch your chin to your neck. Hold for a few seconds, breathe in gradually, and exhale slowly with each exercise. Exhaling with the movement helps relax the muscles. Repeat 10 to 15 times. Relax the neck and back muscles with each neck bend.",
"      </li>",
"      <li>",
"       Shoulder rolls &mdash; In the sitting or standing position, hold the arms at the side with the elbows bent. Try to pinch the shoulder blades together. Roll the shoulders backwards 10 to 15 times, moving in a rhythmic, rowing motion. Rest. Roll the shoulders forwards 10 to 15 times.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Other exercise may include neck rotation, neck tilting, vertical shoulder stretches, upper back stretches, and back bending.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Neck rotation &mdash; Slowly look to the right. Hold for a few seconds. Look to the center. Rest for a few seconds between movements. Repeat 10 to 15 times. Perform on the left side.",
"      </li>",
"      <li>",
"       Neck tilting &mdash; Look straight forward, then tilt the top of the head to the right, trying to touch your right ear to the right shoulder (without moving the shoulder). Hold in place for a few seconds. Return the head to the center. Repeat 10 to 15 times. Repeat on the left side.",
"      </li>",
"      <li>",
"       Vertical shoulder stretches &mdash; In the sitting or standing position, use the right hand to hold the left wrist and pull the arm (and shoulder) up and over the head, towards the right. Hold for five seconds. Keep the left shoulder and back muscles relaxed. Rest and repeat 10 to 15 times. Repeat using left hand to hold right wrist.",
"      </li>",
"      <li>",
"       Upper back stretches &mdash; In the standing position, lean forward from the hips and rest both hands on a low counter with the elbows straight. Exhale, relax the neck and shoulders, and allow the head to fall forward as you round the upper back. This requires the shoulder blades to spread apart and mimics the motion of a cat stretching its back. Exhaling with the motion helps to relax the muscles. Return to the standing position with hands on a counter. Repeat slowly 10 times.",
"      </li>",
"      <li>",
"       Upper back side bends &mdash; Stand or sit up straight in a chair. Bend the trunk to the right while holding the hands together slightly behind the neck for support. Hold for five seconds, and then return to center. Repeat to the left. Repeat 10 to 15 times. Keep the lower back straight or supported against a chair.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Reduce stress",
"     </span>",
"     &nbsp;&mdash;&nbsp;Emotional stress can increase neck tension and interfere with or delay the recovery process. Reducing stress may help to prevent a recurrence of neck pain. Relaxation techniques can relieve musculoskeletal tension. An example of a relaxation exercise is to take a deep breath in, hold it for a few seconds, and then exhale completely. Breathe normally for a few seconds, and then repeat.",
"    </p>",
"    <p>",
"     Other activities that may help to reduce stress include meditation, progressive muscle relaxation, prayer, self-hypnosis, or biofeedback.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Posture",
"     </span>",
"     &nbsp;&mdash;&nbsp;Activities and body positions that prevent or reduce neck pain include those that emphasize a neutral neck position and minimize tension across the supporting muscles and ligaments of the neck. Extremes of range of motion, activities, and body positions that cause constant tension should be minimized or avoided:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Avoid sitting in the same position for prolonged periods of time. Take periodic five minute breaks from the desk, work station, etc. Avoid looking up or down at a computer monitor; adjust it to eye level.",
"      </li>",
"      <li>",
"       Avoid placing pressure over the upper back with backpacks, over-the-shoulder purses, or children riding on your shoulders. Alternatives may include wheeled backpacks or cases, handbags, and having a child walk or ride in a stroller.",
"      </li>",
"      <li>",
"       Do not perform overhead work for prolonged periods at a time.",
"      </li>",
"      <li>",
"       Maintain good posture by holding your head up and keeping your shoulders back and down.",
"      </li>",
"      <li>",
"       Use the car or chair arm rests to keep the arms supported.",
"      </li>",
"      <li>",
"       Sleep with your neck in a neutral position by sleeping with a small pillow under the nape of your neck (sleeping on your back) or sleeping with enough pillows to keep your neck straight in line with your body (sleeping on your side). If you sleep on your back, putting a pillow under the knees can help to flatten the spine and relax the neck muscles. Avoid sleeping on the stomach with the head turned.",
"      </li>",
"      <li>",
"       Carry heavy objects close to your body rather than with outstretched arms.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      OTHER NECK PAIN TREATMENTS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Acupuncture and biofeedback",
"     </span>",
"     &nbsp;&mdash;&nbsp;Acupuncture involves inserting hair-thin, metal needles into the skin at specific points on the body. It causes little to no pain. Biofeedback involves learning to control certain bodily functions, such as muscle tension, which can help to decrease pain.",
"    </p>",
"    <p>",
"     Acupuncture and biofeedback have been used in patients with persistent neck pain with cervical muscle strain. The quality of many of these studies is insufficient to draw firm conclusions regarding their efficacy. One review found that acupuncture may help to relieve chronic neck pain [",
"     <a class=\"abstract\" href=\"UTD.htm?26/35/27188/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Cervical collar",
"     </span>",
"     &nbsp;&mdash;&nbsp;A soft cervical collar is a piece of foam covered with fabric that is worn around the neck to support the head. Routine use of a cervical collar is not recommended because it may delay recovery or allow the neck muscles to weaken. In addition, collars can make neck pain worse in some people due to the fit of the collar.",
"    </p>",
"    <p>",
"     At night, a rolled towel under the neck or a neck pillow can provide comfort and keep the neck in a neutral position. The ear should be aligned with the middle of the shoulder when lying on the back. When lying on the side, the nose should be aligned with the middle of the chest bone. Using one or two regular pillows is not recommended because it can cause too much forward or side-bending of the neck.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h2\">",
"      Injections",
"     </span>",
"     &nbsp;&mdash;&nbsp;Trigger point injections are injections of a local anesthetic medication (eg, lidocaine) into an area of the muscle that is tightened and tender (a trigger point).",
"    </p>",
"    <p>",
"     Trigger point injections may be recommended if other treatments (eg, stretching exercises, massage) do not significantly improve pain. However, there is no good evidence that trigger point injections help to reduce pain or speed healing in the long term. Steroid injections into the neck muscles are not recommended due to the risk of injury to the muscles.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Electrical stimulation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Transcutaneous electrical nerve stimulation (TENS) is a treatment that uses a mild electric current, which is applied to the skin, to decrease pain and increase mobility and strength. Studies of TENS are poorly designed and it is not clear if the treatment is effective [",
"     <a class=\"abstract\" href=\"UTD.htm?26/35/27188/abstract/2\">",
"      2",
"     </a>",
"     ]. However, a trial of TENS is reasonable if other forms of treatment are not successful. A healthcare provider can teach the patient how to perform TENS at home.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      Chiropractic or physical therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Treatment of neck pain by physically handling the muscles, soft tissue, and joints can be performed by several qualified healthcare professionals, including physicians, physical therapists, and chiropractors. This type of treatment may include massage, heat, ultrasound, or electrical stimulation.",
"    </p>",
"    <p>",
"     Some studies have found that treatments that include quick &ldquo;thrusting&rdquo; of the neck are associated with serious injury [",
"     <a class=\"abstract\" href=\"UTD.htm?26/35/27188/abstract/3\">",
"      3",
"     </a>",
"     ]. Aggressive manipulation or adjustments to the cervical spine should be discouraged in elderly patients and those with cervical stenosis. Other treatments that include gentle movement or massage may be safe and helpful for many people, especially when it is combined with stretching and strengthening exercises.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h2\">",
"      Cervical traction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical traction involves the use of weights to realign or pull the spinal column into alignment. Clinical studies have shown that there is no benefit to traction in the treatment of neck pain.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery is not useful for treating most types of neck pain. However, surgery does have a role in relieving symptoms related to a pinched nerve caused by a herniated disc (cervical radiculopathy or cervical spondylotic myelopathy) after a trial of conservative therapy (eg, stretching exercises, physical therapy). People with chronic neck pain who do not improve with the above treatments may benefit from referral to a Spine or Pain Specialty clinic.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H30\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784935681\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5516511\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/31/23026?source=see_link\">",
"      Patient information: Neck pain (The Basics)",
"     </a>",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/0/15363?source=see_link\">",
"      Patient information: Neck fracture (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/45/17106?source=see_link\">",
"      Patient information: Whiplash (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/41/29329?source=see_link\">",
"      Patient information: Torticollis in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/0/39938?source=see_link\">",
"      Patient information: Muscle strain (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/18/43297?source=see_link\">",
"      Patient information: Central spinal cord syndrome (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/8/32898?source=see_link\">",
"      Patient information: Radiculopathy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/57/25490?source=see_link\">",
"      Patient information: Diffuse idiopathic skeletal hyperostosis (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5516519\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/60/26568?source=see_link\">",
"      Cervicogenic headache",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/19/36152?source=see_link\">",
"      Clinical features and diagnosis of cervical radiculopathy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/24/1418?source=see_link\">",
"      Evaluation of the patient with neck pain and cervical spine disorders",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17144?source=see_link\">",
"      Treatment of cervical radiculopathy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/36/23113?source=see_link\">",
"      Treatment of neck pain",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://orthoinfo.aaos.org/\">",
"      file://orthoinfo.aaos.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Physical Medicine and Rehabilitation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aapmr.org/\">",
"      www.aapmr.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Arthritis and Musculoskeletal and Skin Disease",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niams.nih.gov/\">",
"      www.niams.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Physical Therapy Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.apta.org/\">",
"      www.apta.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Arthritis Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.arthritis.org/\">",
"      www.arthritis.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?26/35/27188/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 16, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?26/35/27188?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27188/abstract/1\">",
"      Trinh KV, Graham N, Gross AR, et al. Acupuncture for neck disorders. Cochrane Database Syst Rev 2006; :CD004870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27188/abstract/2\">",
"      Kroeling P, Gross A, Houghton PE, Cervical Overview Group. Electrotherapy for neck disorders. Cochrane Database Syst Rev 2005; :CD004251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27188/abstract/3\">",
"      Gross AR, Hoving JL, Haines TA, et al. A Cochrane review of manipulation and mobilization for mechanical neck disorders. Spine (Phila Pa 1976) 2004; 29:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27188/abstract/4\">",
"      Verhagen AP, Peeters GG, de Bie RA, Oostendorp RA. Conservative treatment for whiplash. Cochrane Database Syst Rev 2001; :CD003338.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f26_35_27188=[""].join("\n");
var outline_f26_35_27188=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           NECK PAIN OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           NECK ANATOMY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           NECK PAIN CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           NECK PAIN TESTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           NECK PAIN TREATMENTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           OTHER NECK PAIN TREATMENTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H30\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/4/6210\" title=\"figure 1\">",
"           Cervical vertebrae anatomy",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/14/2275\" title=\"figure 2\">",
"           Side view of neck bones and muscles",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f26_35_27189="Amiodarone: Patient drug information";
var content_f26_35_27189=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Amiodarone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     see \"Amiodarone: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/41/9882?source=see_link\">",
"     see \"Amiodarone: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F133629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cordarone&reg;;",
"     </li>",
"     <li>",
"      Nexterone&reg;;",
"     </li>",
"     <li>",
"      Pacerone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F133630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Amiodarone Hydrochloride Injection;",
"     </li>",
"     <li>",
"      Apo-Amiodarone&reg;;",
"     </li>",
"     <li>",
"      Ava-Amiodarone;",
"     </li>",
"     <li>",
"      Cordarone&reg;;",
"     </li>",
"     <li>",
"      Dom-Amiodarone;",
"     </li>",
"     <li>",
"      Mylan-Amiodarone;",
"     </li>",
"     <li>",
"      PHL-Amiodarone;",
"     </li>",
"     <li>",
"      PMS-Amiodarone;",
"     </li>",
"     <li>",
"      PRO-Amiodarone;",
"     </li>",
"     <li>",
"      ratio-Amiodarone;",
"     </li>",
"     <li>",
"      Riva-Amiodarone;",
"     </li>",
"     <li>",
"      Sandoz-Amiodarone;",
"     </li>",
"     <li>",
"      Teva-Amiodarone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700624",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is to treat unsafe fast heartbeats only. It may cause risky side effects. Amiodarone may cause lung, thyroid, or liver problems. You will be closely watched when starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a fast heartbeat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701498",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to amiodarone, iodine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a slow heartbeat without a working pacemaker.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697727",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust during care and for some time after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698359",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sunburn.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026701\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to handle heat or cold.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698117",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair thinning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Neck swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10822 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A392849A5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27189=[""].join("\n");
var outline_f26_35_27189=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133629\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133630\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026692\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026694\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026693\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026698\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026699\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026701\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026696\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026697\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026702\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026703\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=related_link\">",
"      Amiodarone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/41/9882?source=related_link\">",
"      Amiodarone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_35_27190="Sirolimus: Patient drug information";
var content_f26_35_27190=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sirolimus: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     see \"Sirolimus: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/14/10472?source=see_link\">",
"     see \"Sirolimus: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rapamune&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F221227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Rapamune&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may add to your chance of getting lymphoma or other cancers.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have happened in patients who take this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sirolimus may have very bad effects if used for liver or lung transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691551",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to keep the body from harming the organ after an organ transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691863",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat graft versus host effects after a bone marrow transplant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2898959",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat soft tissue sarcoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702929",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sirolimus or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697269",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2986760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have skin cancer, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696697",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful about getting vaccines while you are getting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take cyclosporine capsules (Neoral&reg;, Gengraf&reg;) or oral solution (Neoral&reg;) within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust before care begins, during care, and for 3 months after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High cholesterol level.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697866",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696435",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin wound that will not heal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696048",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with other drugs to help the body accept the new organ.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral solution:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put",
"       <sup>",
"        1",
"       </sup>",
"       /",
"       <sub>",
"        4",
"       </sub>",
"       cup of water or orange juice into a cup.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Measure this drug in the oral dose syringe. Empty drug from syringe into cup. Mix well and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694857",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fill container again with",
"       <sup>",
"        1",
"       </sup>",
"       /",
"       <sub>",
"        2",
"       </sub>",
"       cup of water or orange juice. Mix well and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (solution) at room temperature or in a refrigerator. Throw away any part not used after 15 days if stored at room temperature. Throw away any part not used after 1 month if refrigerated.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Liquid (solution) may look hazy when refrigerated. Bring to room temperature and shake gently until haze goes away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699439",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (solution) in a syringe at room temperature for 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11048 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9662981F41-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27190=[""].join("\n");
var outline_f26_35_27190=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221226\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221227\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030687\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030689\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030688\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030693\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030694\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030696\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030691\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030692\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030697\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030698\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=related_link\">",
"      Sirolimus: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/14/10472?source=related_link\">",
"      Sirolimus: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_35_27191="Uterine adenomyosis";
var content_f26_35_27191=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Uterine adenomyosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Elizabeth A Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27191/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/35/27191/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomyosis refers to a disorder in which endometrial glands and stroma are present within the uterine musculature (uterine adenomyomatosis). The ectopic endometrial tissue appears to induce hypertrophy and hyperplasia of the surrounding myometrium, which results in a diffusely enlarged uterus (often termed \"globular\" enlargement) analogous to the concentric enlargement of the pregnant uterus. However, some women have only small areas of diffuse disease that are only apparent by microscopy, whereas others develop nodules (termed adenomyomas), which clinically resemble leiomyomas. The uterus generally does not exceed the size of a pregnant uterus at 12 weeks of gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of adenomyosis has not been determined accurately since the diagnosis can only be made with certainty by microscopic examination of the uterus, typically following hysterectomy. Although generally estimated to affect 20 percent of women, the incidence was approximately 65 percent in one study in which meticulous histopathological analysis of multiple myometrial sections was performed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A full understanding of the epidemiology of the disease is limited by the difficulty in making the diagnosis. Until recently, adenomyosis was only diagnosed at the time of hysterectomy. Most studies suggest that women undergoing hysterectomy for adenomyosis are in the later part of their reproductive years. However, this results in a lack of information about early stages of disease. Studies that use pelvic imaging, rather than hysterectomy, for diagnosis suggest that adenomyosis can be found in adolescents.",
"   </p>",
"   <p>",
"    In addition, the fact that adenomyosis coexists with other uterine diseases, primarily uterine leiomyomas and endometriosis, contributes to the gaps in the understanding of this disease. As an example, persistence of pelvic pain following optimal endometriosis surgical therapy may be confounded by the presence of adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, one study argued that adenomyosis was a variant and not a true disease because the presenting symptoms for hysterectomy were similar with and without the finding of adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/4\">",
"     4",
"    </a>",
"    ]. However, at the time of recruitment, all women were at least 42 years old and women were followed for 10 years, so the cohort represented only perimenopausal women.",
"   </p>",
"   <p>",
"    Other studies suggest, however, that women with adenomyosis do differ from women with other disease processes. A longitudinal study recruiting women starting at age 22, found that compared to women with endometriosis, women with adenomyosis had increasing parity, early menarche and shorter menstrual cycles [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/5\">",
"     5",
"    </a>",
"    ]. Half of the women in both groups had concomitant leiomyomas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A second study utilized a case control model comparing women undergoing hysterectomy where leiomyomas were found on pathologic exam and matched them to women where only adenomyosis was found [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/6\">",
"     6",
"    </a>",
"    ]. In this study, women with adenomyosis were significantly younger and were more likely to have dysmenorrhea, pelvic pain and depression and a history of prior uterine surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/6\">",
"     6",
"    </a>",
"    ]. In a multivariate analysis confined to women with uteri weighing more than 150 grams, women with adenomyosis were more likely to have depression and endometriosis compared to women with only fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adenomyosis appears to be more common in parous than nulliparous women [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. However, a greater number of pregnancies are not associated with a higher risk of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/7\">",
"     7",
"    </a>",
"    ]. The relationship between parity and adenomyosis may be biased since the diagnosis is typically made only at hysterectomy. Interestingly, the situation is just the opposite in women with leiomyomas, in whom parity is associated with a decreased risk of disease.",
"   </p>",
"   <p>",
"    Several studies have reported that prior uterine surgery may also be a risk factor for adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of adenomyosis is not known. The two major theories are that it either develops from endomyometrial invagination of the endometrium or de novo from mullerian rests [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/9\">",
"     9",
"    </a>",
"    ]. A mouse model of adenomyosis supports the invagination hypothesis, facilitated by weakness of degenerating uterine smooth muscle tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/10\">",
"     10",
"    </a>",
"    ]. However, a metaplastic process appears to be more likely given a report of adenomyosis in a woman with Rokitansky-Kuster-Hauser syndrome who lacked eutopic endometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/11\">",
"     11",
"    </a>",
"    ]. There is also increasing molecular evidence that the adenomyotic glands differ in expression of key molecules from eutopic endometrial glands [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/12-16\">",
"     12-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gonadal steroid hormones (estrogen and progesterone) appear to play a role in adenomyosis pathophysiology, as they do in other gynecologic disorders. This conclusion is primarily inferred from the response of symptoms to steroidal treatments. There are, however, studies that suggest that estrogen is produced in adenomyotic tissue and in vitro studies that suggest that aromatase in the endometrium of women with adenomyosis is normalized by gonadotropin releasing hormone (GnRH) agonist treatment and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    , but no studies of direct action on adenomyotic implants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. A murine model of adenomyosis suggests that early exposure to estrogen (in this experiment,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    ) leads to an increased risk of adenomyosis and abnormal myometrium, which also supports the invagination hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, other animal models suggest that pituitary protein hormones, including prolactin and follicle stimulating hormone (FSH), which have direct uterine effects, may also have roles in the pathogenesis of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/10,20-22\">",
"     10,20-22",
"    </a>",
"    ]. Both direct exposure of the uterus to prolactin and hyperprolactinemia secondary to SSRI use appear capable of inducting uterine adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/23\">",
"     23",
"    </a>",
"    ]. This hypothesis is strengthened by the recent work showing both depression and antidepressant use are increased in women with adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is some evidence that adenomyosis and leiomyomas share elements of pathogenesis such as growth factor dysregulation and abnormalities of angiogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/15,24-27\">",
"     15,24-27",
"    </a>",
"    ]. In model systems, the efficacy of some conventional and investigational therapies may be mediated through these systems [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/18,28\">",
"     18,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although adenomyosis and endometriosis both represent disorders of ectopic endometrium and can be a cause of pelvic pain, the two diseases are not thought to be otherwise related. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Just as endometriosis can be localized or diffuse, adenomyosis can be present diffusely throughout the myometrium, or confined to a discrete area termed an adenomyoma. On gross inspection, the uterus with diffuse adenomyosis is uniformly enlarged and boggy, in contrast to the irregular and firm appearance of the fibroid uterus. The average uterine weight is usually between 80 and 200 grams, unless coexisting leiomyomas are present. Upon sectioning the uterus, the myometrial wall appears thickened and often contains small hemorrhagic or chocolate colored areas representing islands of endometrial bleeding. Adenomyomas can clinically resemble leiomyomas. Adenomyomas are not easily excised, unlike myomas, which can be readily shelled out from the surrounding myometrium. A plane is not easily developed and sharp dissection is required.",
"   </p>",
"   <p>",
"    The term cystic is used to describe either diffuse adenomyosis or adenomyomas for which with cysts &ge;1 cm in diameter are seen on imaging studies. The entity &ldquo;juvenile cystic adenomyoma&rdquo; has been used, mainly in reports from Japan, to describe a syndrome in which women 30 years or younger with severe dysmenorrhea have myometrial cysts &ge;1 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/29\">",
"     29",
"    </a>",
"    ].&nbsp;However, authors from other countries have reported cystic adenomyosis in women of a variety of reproductive ages [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/30\">",
"     30",
"    </a>",
"    ].&nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Microscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathognomonic feature of adenomyosis is the presence of endometrial tissue within the myometrium at a distance of at least one low power field (some authorities insist on two low power fields) from the endomyometrial junction. The distance requirement is to preclude mistaking the normal endometrium between muscle fibers at the mucosa for adenomyosis when the specimen is transected for slide preparation. The widespread use of endometrial ablation potentially could confound the diagnosis as the procedure distorts or destroys the",
"    <span class=\"nowrap\">",
"     endometrial/myometrial",
"    </span>",
"    junction.",
"   </p>",
"   <p>",
"    A zone of myometrial hypertrophy and hyperplasia surrounds the adenomatous tissue. The ectopic endometrium may show a functional response to estrogen and progesterone, but usually has an immature proliferative pattern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heavy menstrual bleeding and painful menstruation are the major symptoms of adenomyosis, occurring in approximately 60 and 25 percent of women, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/1\">",
"     1",
"    </a>",
"    ]. Chronic pelvic pain may occur. Symptoms typically are reported to develop between the ages of 40 and 50 years; however, this may reflect the fact that most adenomyosis has historically been diagnosed at hysterectomy. Newer reports using magnetic resonance imaging (MRI) criteria for diagnosis suggest that the disease may cause dysmenorrhea and chronic pelvic pain in adolescents and younger reproductive-age women than previously appreciated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Menorrhagia is possibly related to the increased endometrial surface of the enlarged uterus, while pain may be due to bleeding and swelling of endometrial islands confined by myometrium. Approximately one-third of women are asymptomatic.",
"   </p>",
"   <p>",
"    As discussed above, physical examination usually reveals diffuse uterine enlargement (often termed \"globular\" enlargement), generally not exceeding the size of a pregnant uterus at 12 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/31\">",
"     31",
"    </a>",
"    ]. However, some women have a normal sized uterus while others develop nodules (termed adenomyomas), which clinically resemble leiomyomas. The uterus may be tender.",
"   </p>",
"   <p>",
"    One epidemiologic study noted an increased risk of preterm birth in women with adenomyosis, which was diagnosed by either ultrasound or MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/32\">",
"     32",
"    </a>",
"    ]. This association may have been related to confounders or misdiagnosis of the disease; confirmation is required.",
"   </p>",
"   <p>",
"    Most women with this disorder have another pathologic process in the uterus that often obscures the diagnosis of adenomyosis, and makes the delineation of a symptom profile for \"pure\" adenomyosis difficult. In one review, as an example, leiomyomas, endometriosis, and endometrial polyps were also present in 50, 11, and 7 percent, respectively, of women with adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/1\">",
"     1",
"    </a>",
"    ]. In another study, adenomyosis was suspected on MRI in up to 90 percent of women with endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence that uterine adenomyosis affects the risk of spontaneous abortion or other obstetric outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definitive diagnosis of adenomyosis can only be made from histological examination of a hysterectomy specimen. The preoperative diagnosis is suggested by characteristic clinical manifestations (ie, menorrhagia and dysmenorrhea with a uniformly enlarged uterus) in the absence of endometriosis or leiomyomas.",
"   </p>",
"   <p>",
"    MRI is clearly the best imaging technique, but is expensive. The superiority of MRI compared with transvaginal ultrasonography was illustrated in a prospective study of 20 women undergoing hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/34\">",
"     34",
"    </a>",
"    ]. Adenomyosis was identified preoperatively significantly more often with MRI than transvaginal sonography (15 versus 9 of 17 patients with adenomyosis).",
"   </p>",
"   <p>",
"    MRI characteristically shows areas of increased signal intensity in areas of adenomyosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the characteristic thickening of the junctional zone on T2 weighted imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/33,35\">",
"     33,35",
"    </a>",
"    ]. Given the limited treatment options, MR is best used when trying to exclude malignant uterine neoplasia. It can also be used to distinguish diffuse and focal adenomyosis from leiomyomas, when an accurate diagnosis is important to determine management [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transvaginal ultrasound, although less accurate than MRI, can be useful for assessment of a woman with suspected adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/31\">",
"     31",
"    </a>",
"    ]. A meta-analysis of 14 studies in which women underwent hysterectomy with pathologic confirmation of adenomyosis found that preoperative transvaginal sonography had a sensitivity of 83 percent and specificity of 85 percent for diagnosis of adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The thickening of the junctional zone, characteristic of adenomyosis, can be confused with thickened endometrium in some imaging reports. Thus, clinically, the diagnosis of adenomyosis should be considered when scant tissue is obtained following an endometrial biopsy of thickened endometrium.",
"   </p>",
"   <p>",
"    The only study on use of computed tomography for diagnosis of adenomyosis showed poor diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sensitivity of needle biopsy depends upon several factors, including the extent of disease, number of biopsy specimens obtained, sampling site, needle gauge, and operator experience [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/31\">",
"     31",
"    </a>",
"    ]. Needle biopsy is not a common practice and is reserved for clinical situation in which a malignancy needs to be excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy must always be excluded in women with abnormal uterine bleeding, especially when the uterus is also enlarged. In addition, a significant number of premenopausal women who complain of abnormal genital tract bleeding have anatomic problems within the uterus, such as polyps (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7336?source=see_link\">",
"     \"Endometrial polyps\"",
"    </a>",
"    ), submucous myomata, endometrial hyperplasia, synechiae, adenocarcinoma, or infection (endometritis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adenomyosis may be strongly suspected in women with abnormal uterine bleeding and a diffusely enlarged uterus, and the diagnosis may be confirmed by MR imaging. In the absence of this specific constellation of findings, women with abnormal uterine bleeding require a general evaluation for the many different causes of this symptom. They are not initially evaluated specifically for adenomyosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23944?source=see_link\">",
"     \"Terminology and evaluation of abnormal uterine bleeding in premenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2711?source=see_link\">",
"     \"Postmenopausal uterine bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The causes of secondary dysmenorrhea are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef78903 \" href=\"UTD.htm?18/0/18443\">",
"     table 1",
"    </a>",
"    ). Often these disorders can be excluded based upon appropriate imaging studies, laparoscopy, laboratory examination, or relief of symptoms with empiric therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    .) It is also becoming evident that women with persistent pain following adequate treatment for endometriosis may have adenomyosis as an underlying diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only guaranteed treatment for adenomyosis is total hysterectomy. Since disease is confined to the uterus, ovarian conservation can be employed unless there are other contraindications. There are no large or controlled studies of medical or limited surgical therapy for this disease.",
"   </p>",
"   <p>",
"    Hormonal manipulation with progestins (including the levonorgestrel-releasing intrauterine contraception [IUC]), gonadotropin releasing hormone analogs, or aromatase inhibitors may be effective for reducing menorrhagia and dysmenorrhea, as in endometriosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/39-44\">",
"     39-44",
"    </a>",
"    ]. A single case of successful treatment with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    -containing IUC has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/45\">",
"     45",
"    </a>",
"    ]. Although one study observed a 24 percent reduction in the thickness of the junctional zone on MR after six months of use of the levonorgestrel-releasing IUC [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/43\">",
"     43",
"    </a>",
"    ], enlargement of the uterus and recurrence of symptoms are usually documented within six months after cessation of hormonal therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While estrogen-progestin contraceptives are frequently used as primary treatment for dysmenorrhea, the efficacy of these contraceptives specifically for adenomyosis is not known. Some experts feel that estrogen-progestin contraceptives are not efficacious for treatment of this disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/9\">",
"     9",
"    </a>",
"    ]. My own experience suggests that women with adenomyosis and substantial pain can sometimes find relief with continuous use of estrogen-progestin contraceptives and stopping treatment for two or three days when pain increases, which presumably allows blood trapped in the myometrium to be expelled by the uterus.",
"   </p>",
"   <p>",
"    Conservative surgery using endomyometrial ablation or resection, laparoscopic myometrial electrocoagulation, or excision of adenomyosis has been helpful in some patients, although follow-up has been restricted to three years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As discussed previously, there is not a plane separating adenomyotic tissue from normal myometrium so that surgical excision akin to myomectomy is performed with difficulty. Furthermore, the consistency of the adenomyotic uterus is described as \"woody\" and suturing is difficult in this environment. An observational study suggested that the combination of conservative surgery and GnRH medical therapy following treatment may be superior to surgery alone for symptom control [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uterine artery embolization (UAE) has also been successful in resolving symptoms in some women. One study employed this procedure in 18 women with symptomatic adenomyosis diagnosed by MR or ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/49\">",
"     49",
"    </a>",
"    ]. In contrast to previous series, the authors excluded women with coexistent leiomyomas. Five of nine women followed for at least two years had complete resolution of menorrhagia. However, 8 of the 18 women followed 12 to 73 months required additional treatment due to persistent or recurrent symptoms (five underwent hysterectomy, two took additional medical therapy, and one underwent endometrial ablation). Pathological examination of the five uteruses revealed viable foci of adenomyosis.",
"   </p>",
"   <p>",
"    Another study performed UAE on 19 patients with symptomatic pure or dominant adenomyosis on MRI; all had repeat MRI four months after the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/50\">",
"     50",
"    </a>",
"    ]. Uterine volume decreased significantly after UAE (mean uterine volume reduction 25.1 percent). Sixteen of 18 patients who completed a questionnaire at three months reported an improvement in symptoms, and two reported no change. Eleven patients also completed a questionnaire at 12 months; 10 still reported continued improvement, and one patient reported a worsening of symptoms.",
"   </p>",
"   <p>",
"    The largest and most recent study followed 54 women for at least three years (3.5 to 5.8 years) following UAE, and found that approximately two thirds of the women had long-term decreases in symptom severity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/51\">",
"     51",
"    </a>",
"    ]. Symptom severity decreased by about half in this study and baseline clinical factors did not appear to predict success [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There has been limited experience with treatment outcomes following MRI-guided focused ultrasound surgery for adenomyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. In the case report, there was an initial symptomatic response followed by a spontaneous pregnancy and term vaginal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27191/abstract/52\">",
"     52",
"    </a>",
"    ]. Outcomes for the case series are reported only at six months, but there were both symptom improvement and volume reduction.",
"   </p>",
"   <p>",
"    Based on these findings, hysterectomy still appears to be the treatment of choice for women with significant symptoms who have completed childbearing. However, for young women with extensive adenomyosis, who decline hysterectomy, exploration of alternative treatments for symptomatic relief is warranted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/13/25810?source=see_link\">",
"       \"Patient information: Uterine adenomyosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adenomyosis refers to a disorder in which endometrial glands and stroma are present within the uterine musculature (uterine adenomyomatosis). The ectopic endometrial tissue appears to induce hypertrophy and hyperplasia of the surrounding myometrium, which results in a diffusely enlarged uterus (often termed \"globular\" enlargement) analogous to the concentric enlargement of the pregnant uterus. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of adenomyosis is suggested by characteristic clinical manifestations (ie, menorrhagia and dysmenorrhea with a uniformly enlarged uterus) in the absence of endometriosis or leiomyomas. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging is the most accurate noninvasive diagnostic test, but it is expensive. Transvaginal ultrasonography may suggest the diagnosis, but is not highly accurate (sensitivity and specificity 83 and 85 percent, respectively). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometrial biopsy is often normal because the abnormality is in the myometrium, not the endometrium. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A definitive diagnosis of adenomyosis can only be made from histological examination of hysterectomy specimens. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hysterectomy is the treatment of choice for women with significant symptoms. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/1\">",
"      McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu 1974; 3:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/2\">",
"      Ryan GL, Stolpen A, Van Voorhis BJ. An unusual cause of adolescent dysmenorrhea. Obstet Gynecol 2006; 108:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/3\">",
"      Parker JD, Leondires M, Sinaii N, et al. Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril 2006; 86:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/4\">",
"      Weiss G, Maseelall P, Schott LL, et al. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN). Fertil Steril 2009; 91:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/5\">",
"      Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2008; 90:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/6\">",
"      Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril 2010; 94:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/7\">",
"      Molitor JJ. Adenomyosis: a clinical and pathological appraisal. Am J Obstet Gynecol 1971; 110:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/8\">",
"      Panganamamula UR, Harmanli OH, Isik-Akbay EF, et al. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol 2004; 104:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/9\">",
"      Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998; 4:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/10\">",
"      Mori T, Singtripop T, Kawashima S. Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice? Am J Obstet Gynecol 1991; 165:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/11\">",
"      Enatsu A, Harada T, Yoshida S, et al. Adenomyosis in a patient with the Rokitansky-Kuster-Hauser syndrome. Fertil Steril 2000; 73:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/12\">",
"      Ota, H, Igarashi, S, et al. Distribution of tissue macrophages in uterine muscle layers in patients with adenomyosis. Med Sci Res 1991; 19:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/13\">",
"      Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999; 94:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/14\">",
"      Ota H, Igarashi S, Hatazawa J, Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil Steril 1999; 72:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/15\">",
"      Propst AM, Quade BJ, Gargiulo AR, et al. Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium. Menopause 2001; 8:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/16\">",
"      Propst AM, Quade BJ, Nowak RA, Stewart EA. Granulocyte macrophage colony-stimulating factor in adenomyosis and autologous endometrium. J Soc Gynecol Investig 2002; 9:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/17\">",
"      Yamamoto T, Noguchi T, Tamura T, et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993; 169:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/18\">",
"      Ishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 2003; 79 Suppl 1:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/19\">",
"      Green AR, Styles JA, Parrott EL, et al. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol 2005; 56:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/20\">",
"      Nowak RA, Mora S, Diehl T, et al. Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol Obstet Invest 1999; 48:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/21\">",
"      Stewart EA. Gonadotropins and the uterus: is there a gonad-independent pathway? J Soc Gynecol Investig 2001; 8:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/22\">",
"      Danilovich N, Roy I, Sairam MR. Emergence of uterine pathology during accelerated biological aging in FSH receptor-haploinsufficient mice. Endocrinology 2002; 143:3618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/23\">",
"      Fi&ccedil;icio��lu C, Tekin HI, Ario��lu PF, Okar I. A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats. Acta Eur Fertil 1995; 26:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/24\">",
"      Schindl M, Birner P, Obermair A, et al. Increased microvessel density in adenomyosis uteri. Fertil Steril 2001; 75:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/25\">",
"      Kang S, Zhao J, Liu Q, et al. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ Mol Mutagen 2009; 50:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/26\">",
"      Wang F, Li H, Yang Z, et al. Expression of interleukin-10 in patients with adenomyosis. Fertil Steril 2009; 91:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/27\">",
"      Yang JH, Wu MY, Chen MJ, et al. Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis. Fertil Steril 2009; 91:2193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/28\">",
"      Zhou YF, Mori T, Kudo H, et al. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice. Fertil Steril 2003; 80 Suppl 2:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/29\">",
"      Takeuchi H, Kitade M, Kikuchi I, et al. Diagnosis, laparoscopic management, and histopathologic findings of juvenile cystic adenomyoma: a review of nine cases. Fertil Steril 2010; 94:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/30\">",
"      Troiano RN, Flynn SD, McCarthy S. Cystic adenomyosis of the uterus: MRI. J Magn Reson Imaging 1998; 8:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/31\">",
"      Levgur M. Diagnosis of adenomyosis: a review. J Reprod Med 2007; 52:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/32\">",
"      Juang CM, Chou P, Yen MS, et al. Adenomyosis and risk of preterm delivery. BJOG 2007; 114:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/33\">",
"      Kunz G, Beil D, Huppert P, et al. Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005; 20:2309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/34\">",
"      Ascher SM, Arnold LL, Patt RH, et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology 1994; 190:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/35\">",
"      Reinhold C, Tafazoli F, Mehio A, et al. Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics 1999; 19 Spec No:S147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/36\">",
"      Byun JY, Kim SE, Choi BG, et al. Diffuse and focal adenomyosis: MR imaging findings. Radiographics 1999; 19 Spec No:S161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/37\">",
"      Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. Am J Obstet Gynecol 2009; 201:107.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/38\">",
"      Katsumata Y, Noda M, Tanaka M, et al. [CT appearance of uterine adenomyosis]. Rinsho Hoshasen 1989; 34:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/39\">",
"      Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999; 60:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/40\">",
"      Huang FJ, Kung FT, Chang SY, Hsu TY. Effects of short-course buserelin therapy on adenomyosis. A report of two cases. J Reprod Med 1999; 44:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/41\">",
"      Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997; 68:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/42\">",
"      Kitawaki J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol 2006; 20:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/43\">",
"      Bragheto AM, Caserta N, Bahamondes L, Petta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 2007; 76:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/44\">",
"      Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009; 79:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/45\">",
"      Igarashi M, Abe Y, Fukuda M, et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 2000; 74:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/46\">",
"      Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 1998; 4:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/47\">",
"      McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998; 4:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/48\">",
"      Wang PH, Liu WM, Fuh JL, et al. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril 2009; 92:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/49\">",
"      Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005; 234:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/50\">",
"      Kitamura Y, Allison SJ, Jha RC, et al. MRI of adenomyosis: changes with uterine artery embolization. AJR Am J Roentgenol 2006; 186:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/51\">",
"      Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol 2007; 188:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/52\">",
"      Rabinovici J, Inbar Y, Eylon SC, et al. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 2006; 21:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/53\">",
"      Fukunishi H, Funaki K, Sawada K, et al. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 2008; 15:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27191/abstract/54\">",
"      Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril 2011; 95:900.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5489 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-B2F8B938AB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27191=[""].join("\n");
var outline_f26_35_27191=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Microscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5489\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5489|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/0/18443\" title=\"table 1\">",
"      Causes of secondary dysmenorrhea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7336?source=related_link\">",
"      Endometrial polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/18/35113?source=related_link\">",
"      Overview of causes of genital tract bleeding in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/13/25810?source=related_link\">",
"      Patient information: Uterine adenomyosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2711?source=related_link\">",
"      Postmenopausal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/24/23944?source=related_link\">",
"      Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_35_27192="Uterus position";
var content_f26_35_27192=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal variations in uterine position",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 449px; height: 506px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Position of the uterus:",
"    <br>",
"     (A) Anteverted and markedly anteflexed.",
"     <br>",
"      (B) Anteverted and anteflexed.",
"      <br>",
"       (C) Retroverted and retroflexed.",
"       <br>",
"        (D) Retroverted and markedly retroflexed.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Reproduced with permission from: Lippincott Williams &amp; Wilkins. Copyright &copy; 2008.",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27192=[""].join("\n");
var outline_f26_35_27192=null;
var title_f26_35_27193="Stage IV PBC";
var content_f26_35_27193=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67519&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Stage IV PBC in a 56-year-old who complained of severe fatigue and a lower back pain following an automobile accident",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A biopsy was consistent with primary biliary cirrhosis, stage IV. Note the nodule formation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27193=[""].join("\n");
var outline_f26_35_27193=null;
var title_f26_35_27194="Overview of hemostasis";
var content_f26_35_27194=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of hemostasis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Pier Mannuccio Mannucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/35/27194/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/35/27194/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemostasis is the process of blood clot formation at the site of vessel injury. When a blood vessel wall is disrupted, the hemostatic response must be quick, localized, and carefully regulated. Abnormal bleeding or a propensity to nonphysiologic thrombosis (ie, thrombosis not required for hemostatic regulation) may occur when specific elements of these processes are missing or dysfunctional.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathways of thrombin-stimulated fibrin clot formation and plasmin-induced clot lysis are linked and carefully regulated (",
"      <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef81428 \" href=\"UTD.htm?30/24/31118\">",
"       figure 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/1\">",
"       1",
"      </a>",
"      ]. When they work in coordinated harmony, a clot is laid down initially to stop bleeding, followed by eventual clot lysis and tissue remodeling.",
"     </li>",
"     <li>",
"      Abnormal bleeding can result from diminished thrombin generation (eg, due to factor VIII deficiency) or enhanced clot lysis (eg, due to alpha-2-antiplasmin deficiency). Conversely, excessive production of thrombin (eg, due to an inherited thrombophilia) can lead to excessive thrombosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The elements responsible for normal hemostasis will be reviewed here. Approaches to the patient with abnormal bleeding or abnormal thrombosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link\">",
"     \"Approach to the adult patient with a bleeding diathesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11930?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of the patient with established venous thrombosis\", section on 'Screening for inherited thrombophilia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The uses of platelet function testing and coagulation assays to diagnose hemostatic abnormalities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/59/23482?source=see_link\">",
"     \"Platelet function testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/36/4682?source=see_link\">",
"     \"Clinical use of coagulation tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHASES OF THE HEMOSTATIC PROCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the clotting process is a dynamic, highly interwoven array of multiple processes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/2\">",
"     2",
"    </a>",
"    ], it can be viewed as occurring in four phases, which are discussed in detail in the following sections:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initiation and formation of the platelet plug (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/7/1146?source=see_link\">",
"       \"Platelet biology\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link&amp;anchor=H2#H2\">",
"       \"Congenital and acquired disorders of platelet function\", section on 'Normal platelet function'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Propagation of the clotting process by the coagulation cascade",
"     </li>",
"     <li>",
"      Termination of clotting by antithrombotic control mechanisms",
"     </li>",
"     <li>",
"      Removal of the clot by fibrinolysis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8218?source=see_link\">",
"       \"Disorders of fibrinogen\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21450?source=see_link&amp;anchor=H2#H2\">",
"       \"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis\", section on 'The fibrinolytic system'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     FORMATION OF THE PLATELET PLUG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelets are activated at the site of vascular injury to form a platelet plug that provides the initial hemostatic response to stop bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link&amp;anchor=H2#H2\">",
"     \"Congenital and acquired disorders of platelet function\", section on 'Normal platelet function'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/7/1146?source=see_link\">",
"     \"Platelet biology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The functional response of activated platelets involves four different processes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Adhesion &mdash; the deposition of platelets on the subendothelial matrix",
"     </li>",
"     <li>",
"      Aggregation &mdash; platelet-platelet cohesion",
"     </li>",
"     <li>",
"      Secretion &mdash; the release of platelet granule proteins",
"     </li>",
"     <li>",
"      Procoagulant activity &mdash; the enhancement of thrombin generation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Platelet activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of physiologic platelet stimuli including adenosine diphosphate (ADP), epinephrine, thrombin, and collagen. ADP and epinephrine are relatively weak platelet activators, while collagen and thrombin are the most potent platelet activators.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Collagen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intact endothelium prevents the adherence of platelets by the production of nitric oxide and prostacyclin. Intimal injury impairs these processes and exposes subendothelial elements such as microfibrils, laminin, and collagen. These factors lead to the adherence of platelets, platelet activation, and secretion.",
"   </p>",
"   <p>",
"    The integrin glycoproteins",
"    <span class=\"nowrap\">",
"     GPIa/IIa",
"    </span>",
"    (also known as alpha2 beta1) and GPVI are the two most important platelet collagen receptors, playing critical roles in platelet adhesion and activation, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with",
"    <span class=\"nowrap\">",
"     GPIa/IIa",
"    </span>",
"    deficiency generally have mild bleeding diathesis, while severe spontaneous bleeding has been reported with platelet GPVI deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Thrombin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombin activation of cells is mediated by a family of G-protein coupled protease-activated receptors (PARs) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Platelets have a dual receptor system for thrombin, with two distinct receptors (PAR-1, and PAR-4). Thrombin cleaves the amino-terminal exodomain of PAR, exposing a new amino-terminus, which then serves as a tethered ligand that binds intramolecularly to the body of the receptor to initiate transmembrane signaling [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an animal model of laser-induced vascular injury, it was shown that the tissue factor-mediated pathway of thrombin generation, rather than the collagen-induced GPVI-mediated pathway, was the major route leading to platelet activation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Platelet adhesion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following activation, platelets undergo significant shape changes, producing elongated pseudopods that make the platelets extremely adhesive. Platelet adhesion is primarily mediated by the binding of platelet surface receptor GP",
"    <span class=\"nowrap\">",
"     Ib/IX/V",
"    </span>",
"    complex to von Willebrand factor (VWF) in the subendothelial matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/10\">",
"     10",
"    </a>",
"    ]. Deficiency of any component of the GP",
"    <span class=\"nowrap\">",
"     Ib/IX/V",
"    </span>",
"    complex or VWF leads to congenital bleeding disorders: Bernard-Soulier disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/11\">",
"     11",
"    </a>",
"    ] and von Willebrand disease, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17049?source=see_link\">",
"     \"Biology and normal function of von Willebrand factor\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link&amp;anchor=H30#H30\">",
"     \"Approach to the adult patient with thrombocytopenia\", section on 'Bernard-Soulier syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, there are other adhesive interactions that contribute to platelet adhesion. One example is binding of the platelet collagen receptor GP",
"    <span class=\"nowrap\">",
"     Ia/IIa",
"    </span>",
"    to collagen fibrils in the matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Platelet aggregation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelet activation results in both exposure of and conformational changes in the GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    receptor on the platelet surface, leading to binding of both immobilized VWF and fibrinogen [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    is a member of a superfamily of adhesive protein receptors called integrins that are found in many different cell types. The GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    complex (integrin alpha IIb beta 3) is the most abundant receptor on the platelet surface, with about 80,000 complexes per platelet. GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    does not bind fibrinogen, a divalent symmetrical molecule that bridges activated platelets, on nonstimulated platelets. However, following platelet stimulation (eg, by thrombin, collagen or ADP), GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    undergoes a conformational change and is converted from a low affinity to a high affinity fibrinogen receptor, a process referred to as \"inside-out\" signaling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/7/1146?source=see_link&amp;anchor=H30#H30\">",
"     \"Platelet biology\", section on 'GPIIb/IIIa activation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8218?source=see_link\">",
"     \"Disorders of fibrinogen\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to mediating platelet aggregation, the cytosolic portion of the activated GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    complex binds to the platelet cytoskeleton and can mediate platelet spreading and clot retraction, which has been referred to as \"outside-in\" integrin signaling. Thus, the GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    complex integrates receptor-ligand interactions that occur on the external face of the membrane with cytosolic events in a bidirectional fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]; it is the final common pathway for platelet aggregation, irrespective of the mode of platelet stimulation.",
"   </p>",
"   <p>",
"    The importance of GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    is illustrated by the bleeding disorder in Glanzmann thrombasthenia, which is characterized by mutations in the gene for either the alpha IIb or the beta-3 subunit [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/18\">",
"     18",
"    </a>",
"    ], as well as the clinical utility of GP",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    antagonists in the treatment of coronary disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link&amp;anchor=H30#H30\">",
"     \"Congenital and acquired disorders of platelet function\", section on 'Glanzmann thrombasthenia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=see_link\">",
"     \"Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Platelet secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelets secrete a variety of substances from their granules upon cell stimulation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ADP and serotonin stimulate and recruit additional platelets [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/19\">",
"       19",
"      </a>",
"      ]. Platelet-released serotonin normally causes vasodilation; however, it can induce vasoconstriction in the presence of damaged or abnormal (dysfunctional) endothelium. ADP-activated platelets increase the surface expression of intercellular adhesion molecule (ICAM)-1 on endothelial cells [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fibronectin and thrombospondin are adhesive proteins that may reinforce and stabilize platelet aggregates.",
"     </li>",
"     <li>",
"      Fibrinogen is released from platelet alpha granules, providing a source of fibrinogen at sites of endothelial injury in addition to that present in plasma [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Thromboxane A2, a prostaglandin metabolite, promotes vasoconstriction and further platelet aggregation.",
"     </li>",
"     <li>",
"      Growth factors, such as platelet-derived growth factor (PDGF), have potent mitogenic effect on smooth muscle cells. The release of PDGF from platelets at the site of vascular injury probably mediates tissue repair physiologically and, at a site of repeated injuries, may contribute to the development of atherosclerosis and coronary reocclusion following angioplasty. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=see_link\">",
"       \"The role of platelets in coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Release of the thiol isomerase, protein disulfide isomerase (PDI), by platelets and disrupted vessel wall cells may serve to activate tissue factor and enhance the generation of fibrin and platelet thrombus formation at sites of vascular injury [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Procoagulant activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelet procoagulant activity is an important aspect of platelet activation and involves both exposure of procoagulant phospholipids, primarily phosphatidylserine, and the subsequent assembly of the enzyme complexes in the clotting cascade on the platelet surface [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/24\">",
"     24",
"    </a>",
"    ]. These complexes are an important example of the close interrelationship between platelet activation and activation of the clotting cascade (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Multicomponent complexes'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLOTTING CASCADE AND PROPAGATION OF THE CLOT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central feature of the clotting cascade is the sequential activation of a series of proenzymes or inactive precursor proteins (zymogens) to active enzymes, resulting in significant stepwise response amplification. As an example, the generation of a small number of factor VIIa molecules will activate many molecules of factor X, which in turn generates even larger numbers of thrombin molecules, which then converts fibrinogen to fibrin. The resultant local generation of fibrin, in turn, enmeshes and reinforces the platelet plug.",
"   </p>",
"   <p>",
"    The function of these enzymes is markedly facilitated by the formation of multiple component macromolecular complexes, such as the tenases (X-ase) that activate factor X and the prothrombinase which produces thrombin from prothrombin (see below).",
"   </p>",
"   <p>",
"    All of the procoagulants are synthesized in the liver except VWF, which is synthesized in megakaryocytes and endothelial cells. Post-translational modification of these factors is known to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/25\">",
"     25",
"    </a>",
"    ]. The best characterized modifications occur in the vitamin K-dependent procoagulants (ie, prothrombin, factors VII, IX, and X) and anticoagulants (ie, protein C and protein S). For each of these factors, vitamin K-dependent carboxylated glutamic acid residues function as calcium binding sites that are important in the assembly of the membrane bound macromolecular procoagulant complexes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/20999?source=see_link\">",
"     \"Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, the clotting cascade is depicted as consisting of an intrinsic and extrinsic pathway (",
"    <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The intrinsic pathway is initiated by the exposure of blood to a negatively charged surface (such as celite, kaolin, or silica in the in vitro activated partial thromboplastin clotting time [aPTT]).",
"     </li>",
"     <li>",
"      The extrinsic pathway is activated by tissue factor exposed at the site of injury or tissue factor-like material (thromboplastin, TPL in the in vitro prothrombin clotting time [PT]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both pathways converge on the activation of factor X which, as a component of prothrombinase, converts prothrombin to thrombin, the final enzyme of the clotting cascade. Thrombin converts fibrinogen from a soluble plasma protein into an insoluble fibrin clot. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8218?source=see_link&amp;anchor=H6#H6\">",
"     \"Disorders of fibrinogen\", section on 'Fibrin polymerization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Thrombin generation",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the above-noted classical view of the clotting cascade has been useful in the interpretation of clotting times (eg, PT and aPTT) (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/36/4682?source=see_link\">",
"     \"Clinical use of coagulation tests\"",
"    </a>",
"    ), it may not be physiologically accurate.",
"   </p>",
"   <p>",
"    It is now established that the generation or exposure of TF at the wound site, and its interaction with factor VII, is the",
"    <strong>",
"     primary",
"    </strong>",
"    physiologic event in initiating clotting [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/27\">",
"     27",
"    </a>",
"    ], and that components of the intrinsic pathway (ie, factors VIII, IX, XI) are responsible for",
"    <strong>",
"     amplification",
"    </strong>",
"    of this process only after a small initial amount of thrombin has been generated through the extrinsic pathway. This was shown via the time course of thrombin generation, which demonstrated an initiation phase with only a small amount of thrombin being generated, followed by a propagation phase consisting of the bulk of thrombin generation, and finally cessation of thrombin generation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Standard laboratory clotting tests, which detect initial fibrin clot formation, primarily measure the initiation and not the propagation phase of clotting. The initiation phase is largely mediated by the activation of factor X by tissue",
"    <span class=\"nowrap\">",
"     factor/factor",
"    </span>",
"    VIIa (",
"    <a class=\"graphic graphic_figure graphicRef75450 \" href=\"UTD.htm?12/20/12610\">",
"     figure 3",
"    </a>",
"    ), giving rise to a small amount of thrombin, which in turn activates factor V, factor VIII, factor XI, and platelets, exposing anionic phospholipids on the platelet surface to support the assembly of the multi-component enzyme complexes (intrinsic tenase and prothrombinase) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/29\">",
"     29",
"    </a>",
"    ]. Thus, the initial small amount of generated thrombin primes the clotting cascade and activates platelets, which then leads to explosive thrombin generation. This is illustrated in the Amplification and Propagation phases in the figure (",
"    <a class=\"graphic graphic_figure graphicRef75450 \" href=\"UTD.htm?12/20/12610\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    While activated platelets clearly play a critical role in enhancing blood coagulation, bleeding manifestations of thrombocytopenia and clotting factor deficiency are quite distinct; the former usually manifests as mucosal bleeding while the latter is associated with tissue hematomas and joint bleeding (",
"    <a class=\"graphic graphic_table graphicRef77834 \" href=\"UTD.htm?2/43/2748\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, if platelets are indispensable for efficient blood clotting, bleeding from severe thrombocytopenia should also have features of clotting factor deficiency. This apparent paradox may be partially explained by the observation that only a small number of platelets are required for adequate fibrin formation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/30\">",
"     30",
"    </a>",
"    ]. Thus, even in the presence of severe thrombocytopenia (eg, platelet counts of approximately",
"    <span class=\"nowrap\">",
"     10,000/microL),",
"    </span>",
"    patients usually do not have joint bleeds and only manifest mucosal bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Multicomponent complexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four multicomponent macromolecular complexes play a major role in the coagulation pathways: three procoagulant complexes (extrinsic and intrinsic X-ase and prothrombinase); and one anticoagulant complex. These complexes consist of the enzyme, a cofactor protein, the enzyme substrate, assembled on cellular membrane components (anionic phospholipid surfaces) in the presence of calcium (",
"    <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extrinsic X-ase (ten-ase) &ndash; consists of",
"      <sup>",
"      </sup>",
"      activated factor VII (factor VIIa) as the protease, tissue factor as the cofactor, and factor X (Stuart factor) as the substrate [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. The extrinsic X-ase activates both factor X and factor IX [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/34,35\">",
"       34,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intrinsic X-ase (ten-ase) &ndash; consists of factor IXa as the protease, activated factor VIII (factor VIIIa) as the cofactor, and factor X as the substrate [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/36\">",
"       36",
"      </a>",
"      ]. Factor IXa can be generated by the extrinsic X-ase or via activation of the intrinsic pathway, either directly or indirectly via thrombin-induced activation of factor XI.",
"     </li>",
"     <li>",
"      Prothrombinase &ndash; consists of factor Xa as the protease, factor Va as the cofactor, and prothrombin (factor II) as the substrate.",
"     </li>",
"     <li>",
"      The protein C anticoagulant complex &ndash; consists of thrombin (factor IIa) as the enzyme, thrombomodulin as the cofactor, and protein C as the substrate. In addition, endothelial protein C receptor (EPCR), which is primarily expressed on the endothelium of large blood vessels, functions as a receptor for protein C and further accelerates the activation of protein C by the",
"      <span class=\"nowrap\">",
"       thrombin/thrombomodulin",
"      </span>",
"      complex [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The advantages of these multicomponent enzyme complexes can be illustrated by the prothrombinase complex [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/38\">",
"     38",
"    </a>",
"    ]. When platelets are activated, anionic lipids &ndash; primarily phosphatidylserine &ndash; become exposed on the platelet surface, and factor V, stored in platelet granules, is released and bound to these anionic lipids. Factor V is activated to factor Va by the initial trace amount of thrombin generated from interactions between tissue factor and factor VIIa at the wound site. Together with the appropriate anionic membrane phospholipids and calcium, this activated factor Xa and its cofactor, factor Va, form the prothrombinase complex, which cleaves prothrombin (factor II) to thrombin (factor IIa).",
"   </p>",
"   <p>",
"    Because of its extremely favorable local proximity, thrombin generation by the prothrombinase complex is approximately 300,000 times more efficient compared with that generated by factor Xa and prothrombin alone. In addition, factor Xa bound to factor Va is also relatively protected from inhibition by circulating inhibitors such as antithrombin. The net effect is that thrombin generation is dramatically enhanced on the surface of activated platelets and restricted to sites of vascular injury.",
"   </p>",
"   <p>",
"    The importance of the procoagulant effect of platelets in the assembly of multicomponent complexes is illustrated by congenital platelet function disorders in which the platelet membrane phospholipids do not change in response to platelet activation. Scott syndrome is an autosomal recessive disorder caused by mutation of TMEM16F, a protein partly responsible for lipid scramblase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/24,38-42\">",
"     24,38-42",
"    </a>",
"    ]. This protein forms a calcium-activated channel that promotes the &ldquo;scrambling&rdquo; (ie, disrupting the membrane gradient) of phosphatidylserine, moving it from the inner leaflet of the platelet plasma membrane to the outer leaflet [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/42\">",
"     42",
"    </a>",
"    ]. Activated platelets with phosphatidylserine on their surface bind factor Va and initiate assembly of the prothrombinase complex.",
"   </p>",
"   <p>",
"    Patients with Scott syndrome have impaired thrombin generation, clinically prolonged bleeding, and a reduced tendency to form thromboses. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Extrinsic pathway",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H603267846\">",
"    <span class=\"h3\">",
"     Tissue factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vessel wall damage leads to expression of tissue factor (TF, tissue thromboplastin), an integral membrane glycoprotein [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/43\">",
"     43",
"    </a>",
"    ]. Tissue factor is not normally expressed on vascular endothelial cells or monocytes but is constitutively expressed on certain biological surfaces, such as skin, organ surfaces, vascular adventitia, and many of their malignant counterparts. Normally, TF is exposed to blood flow only after endothelial damage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of the TF is in a functionally inactive (&ldquo;encrypted&rdquo;) state. Upon cell lysis or certain in vitro conditions, such as stimulation by calcium ionophore, TF will become activated (&ldquo;de-encrypted&rdquo;) and support FVIIa binding and activation of factor X. The encrypted state may be due to a pair of free cysteine residues (Cys186 and Cys209) which would become linked into a disulfide bond upon cell perturbation, leading to an allosteric change in the conformation of TF resulting in its active de-encrypted state [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Protein disulfide isomerase (PDI), glutathione, and nitric oxide have all been implicated in mediating this process [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/46\">",
"     46",
"    </a>",
"    ]. However, not all of the data are consistent and whether Cys186 and Cys209 are involved in the de-encryption of TF remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissue factor may also circulate in the blood, associated with cell-derived membrane microvesicles as well as in a soluble, alternatively-spliced form [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. These microvesicles derive from lipid rafts on the surface of stimulated",
"    <span class=\"nowrap\">",
"     monocytes/macrophages,",
"    </span>",
"    and are capable of fusing with, and initiating coagulation on, activated platelets [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/52\">",
"     52",
"    </a>",
"    ]. In addition to assembling clotting reactions on their surface, platelets may also synthesize their own tissue factor in order to generate thrombin in a timely and spatially circumscribed process [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/53\">",
"     53",
"    </a>",
"    ], although this has been called into question [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1224?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathogenesis of the hypercoagulable state associated with malignancy\", section on 'Tissue factor-bearing microparticles'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H603267853\">",
"    <span class=\"h3\">",
"     Activation of factors VII, X, and IX",
"    </span>",
"    &nbsp;&mdash;&nbsp;TF serves as the cofactor required for the production of activated factor VII (FVIIa) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. The TF-FVIIa complex activates factors X [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/31,32\">",
"     31,32",
"    </a>",
"    ] and IX [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Activation of factor X occurs at the Arg52-Ile53 peptide bond in the heavy chain of factor X, leading to the formation of the serine protease Xa [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/33\">",
"     33",
"    </a>",
"    ]. Factor IXa in complex with its cofactor factor VIIIa also activates factor X (the intrinsic X-ase as noted above) (",
"    <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This dual pathway of factor X activation (ie, directly and indirectly via activation of factor IX) is necessary because of the limited amount of TF generated in vivo and the presence of the tissue factor pathway inhibitor (TFPI) which, when complexed with factor Xa, inhibits the",
"    <span class=\"nowrap\">",
"     TF/FVIIa",
"    </span>",
"    complex [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/57\">",
"     57",
"    </a>",
"    ]. Thus, sustained generation of thrombin depends upon the activation of factor IX and its cofactor factor VIII. This process is amplified because factor VIII is activated by both factor Xa and thrombin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/31,58\">",
"     31,58",
"    </a>",
"    ] and factor IXa by thrombin-induced activation of factor XI [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/59-63\">",
"     59-63",
"    </a>",
"    ]. As a result, there is a progressive increase in factor VIII and factor IX activation as factor Xa and thrombin are formed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H603267860\">",
"    <span class=\"h3\">",
"     Continuation of the coagulation cascade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once factor X has been activated, the coagulation pathway proceeds as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Factor V, released from platelet alpha granules during platelet activation and cleaved by thrombin to form activated factor V (factor Va), binds factor Xa [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/64-67\">",
"       64-67",
"      </a>",
"      ]. Platelet factor V appears to be more important for assembly of the prothrombinase complex than circulating factor V [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Factor Xa linked to factor Va on the platelet phospholipid surface forms the prothrombinase complex, which converts one molecule of prothrombin (factor II) to one molecule of its activated form, thrombin (factor IIa) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/69,70\">",
"       69,70",
"      </a>",
"      ]. This process also results in the formation of one molecule of the prothrombin activation fragment F1+2 (F1.2).",
"     </li>",
"     <li>",
"      Thrombin converts fibrinogen to fibrin [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/71\">",
"       71",
"      </a>",
"      ], which undergoes polymerization. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8218?source=see_link&amp;anchor=H3#H3\">",
"       \"Disorders of fibrinogen\", section on 'Fibrinogen structure and function'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Activated factor XIII (factor XIIIa) stabilizes and crosslinks overlapping fibrin stands [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/72\">",
"       72",
"      </a>",
"      ]. The formation of factor XIIIa is promoted by the complexing of thrombin, fibrin, and factor XIII [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, thrombin also accelerates the activation of factors XI and VIII, in addition to factor V [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/31,58-61,65\">",
"     31,58-61,65",
"    </a>",
"    ]. Activated factor XI in turn activates factor IX. Thus, factor XI activation by thrombin may function as an adjunctive activation pathway, the absence of which may account for delayed bleeding episodes in factor XI deficient patients, usually in a postoperative setting (see",
"    <a class=\"local\" href=\"#H28\">",
"     'Thrombin-activatable fibrinolysis inhibitor'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/14/37097?source=see_link&amp;anchor=H3#H3\">",
"     \"Factor XI deficiency\", section on 'Role in coagulation'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Intrinsic pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial phase of the intrinsic or contact activation pathway consists of several plasma proteins &mdash; factor XII (Hageman factor), prekallikrein (Fletcher factor) and high molecular weight kininogen (HMWK, Fitzgerald factor) - which are activated by contact with negatively charged surfaces and which initiate the following sequence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activated factor XII, in conjunction with HMWK, activates factor XI, which, in turn, activates factor IX.",
"     </li>",
"     <li>",
"      Factor IXa in complex with factor VIIIa forms the intrinsic X-ase, leading to the formation of factor Xa. Factor VIII is activated by both factor Xa and thrombin [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/31,58\">",
"       31,58",
"      </a>",
"      ]. Thus, there is a progressive increase in factor VIII activation as factor Xa and thrombin are formed. Thrombin also increases the generation of factor IXa via the activation of factor XI [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/59,60,62,63\">",
"       59,60,62,63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The remainder of the intrinsic pathway uses the same cascade as the extrinsic pathway (the common pathway) involving factors V, prothrombin, and fibrinogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H349234200\">",
"    <span class=\"h3\">",
"     Critical role of polyphosphate in initiating blood clotting via the intrinsic pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inorganic polyphosphate (polyP) is a linear highly anionic polymer of orthophosphates linked by high-energy phosphoanhydride bonds. It is ubiquitous in biology and can vary from a few to several thousand phosphate units in polymer length, depending on the organisms and tissues from which it is derived. In microorganisms, polyP is synthesized from ATP and may serve as an energy store allowing the bacteria to resynthesize ATP in times of starvation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/74\">",
"     74",
"    </a>",
"    ]. PolyP is also stored in human platelet dense granules and is efficiently released upon platelet activation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/75\">",
"     75",
"    </a>",
"    ]. In contrast to microbial polyP, platelet polyP is smaller, consisting of 60 to 100 phosphate units.",
"   </p>",
"   <p>",
"    With its multiple anionic charges, polyP is a potent procoagulant, and it likely represents the &ldquo;physiological&rdquo; or &ldquo;pathological&rdquo; negatively charged surface that triggers blood coagulation via the intrinsic pathway. The source of polyP in this setting may derive from injured tissues at the wound site or a microbial source in the case of an infection. In addition to triggering intrinsic pathway activation, polyP has other effects on blood clotting. It accelerates factor V activation, abrogates the inhibitory effect of tissue factor pathway inhibitor (TFPI), enhances fibrin polymerization (making the fibrils thicker), and accelerates factor XI activation by thrombin. The potency of polyP is dependent on its chain length. Long-chain polyP (from a microbial source) is efficient in carrying out all four functions, while medium-size polyP (from platelets) is less effective in triggering the intrinsic pathway but effective in accelerating blood clotting once it is initiated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Deficiencies of initial intrinsic pathway proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physiologic relevance of the initial complex of the intrinsic pathway is not established. Deficiencies in these proteins (prekallikrein, HMWK, and factor XII) are not associated with bleeding tendencies, suggesting that the initiation portion of the intrinsic pathway (the contact phase) is not very important in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations in factor XII have been seen in a subset of patients with hereditary angioedema and normal C1 inhibitor levels, although the bleeding phenomena and coagulation defects in these patients have not been well characterized. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5080?source=see_link\">",
"     \"Type III hereditary angioedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, bleeding is seen with deficiency of factor XI [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/79\">",
"     79",
"    </a>",
"    ], suggesting that factor XI plays an important hemostatic role, independent of contact activation and factor XII. One likely mechanism is that thrombin feedback activates factor XI, with polyP, released from activated platelets or derived from injured tissues, serving as a cofactor [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/59-61,80\">",
"     59-61,80",
"    </a>",
"    ]. Factor XIa then activates factor IX, which leads to further thrombin formation after the clot has been formed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This interpretation is also consistent with the phenotype observed in mice deficient in either factor XII or factor XI. These mice do not exhibit any bleeding problems under normal circumstances, similar to patients deficient in factor XII or factor XI, but surprisingly, they are protected from arterial thrombosis in experimental thrombosis models [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. In this regard, it is interesting that patients severely deficient in factor XI (&lt;15 percent), are reported to be protected from ischemic stroke but not myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/83\">",
"     83",
"    </a>",
"    ]. Genetic polymorphisms of factor XII have also been linked to an increased incidence of thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/84-86\">",
"     84-86",
"    </a>",
"    ]. These data suggest that the additional thrombin generated via the tertiary amplification pathway is important in pathological arterial thrombus formation.",
"   </p>",
"   <p>",
"    This mechanism also provides a rationale by which bleeding can occur in patients with factor XI deficiency: increased fibrinolysis due to diminished activation of thrombin-activatable fibrinolysis inhibitor (TAFI) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/60,87,88\">",
"     60,87,88",
"    </a>",
"    ]. The relatively high concentration of thrombin required within the clot for activation of TAFI appears to come from thrombin-mediated factor XI activation after the clot has been formed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/87\">",
"     87",
"    </a>",
"    ]. Thus, in the absence of factor XI, sufficient TAFI is not generated in order to protect the clot from lysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/14/37097?source=see_link\">",
"     \"Factor XI deficiency\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H28\">",
"     'Thrombin-activatable fibrinolysis inhibitor'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CONTROL MECHANISMS AND TERMINATION OF CLOTTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interactions between activated platelets and the clotting cascade, with their subsequent amplification, give rise to a hemostatic response that is rapid and localized to the injury site. It is also potentially explosive, and if unchecked, could lead to thrombosis, vascular inflammation, and tissue damage. Fortunately, coagulation is modulated by a number of mechanisms: dilution of procoagulants in flowing blood, removal of activated factors through the reticuloendothelial system, especially in the liver, and control of the activated procoagulants and platelets by natural antithrombotic pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/1\">",
"     1",
"    </a>",
"    ]. These antithrombotic pathways are all anchored on vascular endothelial cells, which play an active role in maintaining the fluidity of blood.",
"   </p>",
"   <p>",
"    The termination phase of the coagulation process involves two circulating enzyme inhibitors, antithrombin (formerly called antithrombin III) and tissue factor pathway inhibitor and a clotting-initiated inhibitory process, the protein C pathway. In addition, prostacyclin, thromboxane, and nitric oxide modulate vascular and platelet reactivity.",
"   </p>",
"   <p>",
"    This termination phase is critical in mediating the extent of clot formation, as demonstrated by the thrombotic disorders present in individuals with deficiencies in these pathways. Examples include deficiencies of antithrombin, protein C, and protein S. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Antithrombin, heparin, and heparan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antithrombin (AT) is a circulating plasma protease inhibitor. It neutralizes most of the enzymes in the clotting cascade, especially thrombin, factors Xa, and IXa, as well as factor XIIa and factor XIa, by forming equimolar, irreversible complexes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/89\">",
"     89",
"    </a>",
"    ]. AT has two active functional sites, the reactive center, Arg393-Ser394, and the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    binding site located at the amino terminus of the molecule [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/89\">",
"     89",
"    </a>",
"    ]. The binding of endogenous or exogenous heparins to the heparin binding site on AT produces a conformational change in AT which accelerates the inactivating process 1000 to 4000-fold (",
"    <a class=\"graphic graphic_figure graphicRef64839 \" href=\"UTD.htm?35/16/36110\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33930?source=see_link\">",
"     \"Therapeutic use of heparin and low molecular weight heparin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Heparins contain a specific pentasaccharide (",
"    <a class=\"graphic graphic_figure graphicRef64839 \" href=\"UTD.htm?35/16/36110\">",
"     figure 4",
"    </a>",
"    ) that is important for binding to AT. The glycosaminoglycan heparan sulfate found on endothelial surfaces also contains this pentasaccharide and may mediate part of the physiologic action of AT [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/90-92\">",
"     90-92",
"    </a>",
"    ]. This endothelial system in which the cell surface is coated with activated AT is poised to rapidly inactivate any excess thrombin in the general circulation. The potential of this system is magnified by the surface-volume geometry of the microcirculation, in which 1 mL of blood can be exposed to as much as 5000 cm",
"    <sup>",
"     2",
"    </sup>",
"    of endothelial surface.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Activated protein C and protein S",
"    </span>",
"    &nbsp;&mdash;&nbsp;As clot formation progresses, thrombin (factor IIa) binds to thrombomodulin (TM), an integral membrane protein on the endothelial cell surface [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/93\">",
"     93",
"    </a>",
"    ]. Binding of thrombin to TM induces a conformational change in thrombin, which changes its substrate specificity such that it acquires the ability to activate protein C and no longer promotes platelet activation or the cleavage of fibrinogen [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/94-96\">",
"     94-96",
"    </a>",
"    ]. Activation of protein C by the thrombin-TM complex is enhanced by an endothelial receptor for protein C [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/97-99\">",
"     97-99",
"    </a>",
"    ]. As a testament to this TM-induced change of function for thrombin, a knockout mouse model in which the TM gene was ablated from vascular endothelium was associated with unfettered activation of the coagulation system and widespread juvenile-onset thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Activated protein C (APC), in association with protein S on phospholipid surfaces, proteolytically inactivates factors Va and VIIIa, thereby inactivating the prothrombinase and the intrinsic X-ase, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/101-104\">",
"     101-104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Factor Va is first cleaved at Arg506 and then at Arg306 and Arg679 by APC. The peptide bond cleavage at Arg506 is essential for the exposure of cleavage sites at Arg306 and Arg679 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/102\">",
"       102",
"      </a>",
"      ]. Factor V Leiden, in which the arginine at position 506 is replaced by glutamine, is not susceptible to cleavage at position 506 by activated protein C and is therefore inactivated more slowly, resulting in a hypercoagulable state. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/35/28218?source=see_link\">",
"       \"Activated protein C resistance and factor V Leiden\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Factor V cleaved at position 506 is also thought to be a cofactor, along with protein S, in supporting the role of activated protein C in the degradation of factors Va and VIIIa [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/105\">",
"       105",
"      </a>",
"      ]. Thus, lack of this cleavage product decreases the anticoagulant activity of activated protein C, further increasing the hypercoagulable state in patients with factor V Leiden [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/106\">",
"       106",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Factor VIIIa is first cleaved at Arg336 and then Arg562 by APC [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/104\">",
"       104",
"      </a>",
"      ]. The rate of APC-mediated inactivation is increased several fold by protein S, an effect that is impaired by factor IXa.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Protein S circulates in two forms. In the free form, it is active as an anticoagulant; in the bound form, it is complexed to C4b binding protein of the complement system and is functionally inactive. C4b binding protein is an acute-phase reactant that increases in concentration in inflammatory states; as a result, the activity of free protein S is reduced in these conditions, enhancing the likelihood of thrombosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Tissue factor pathway inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue factor pathway inhibitor (TFPI) circulates in plasma, but at very low concentrations in contrast to AT [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/107\">",
"     107",
"    </a>",
"    ]. TFPI inhibits factor X activation in two ways: it directly inhibits factor Xa; and it complexes with factor Xa and the complex inhibits",
"    <span class=\"nowrap\">",
"     TF/FVIIa,",
"    </span>",
"    thereby impairing the triggering mechanism of the extrinsic pathway (",
"    <a class=\"graphic graphic_figure graphicRef75450 \" href=\"UTD.htm?12/20/12610\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/108-110\">",
"     108-110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TFPI is primarily synthesized by the microvascular endothelium. About 20 percent of TFPI circulates in plasma in association with lipoproteins [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/111\">",
"     111",
"    </a>",
"    ], while the majority remains associated with the endothelial surface, apparently bound to cell surface glycosaminoglycans. The plasma concentration of TFPI is greatly increased following intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    administration; this release of endothelial TFPI may contribute to the antithrombotic efficacy of heparin and low-molecular-weight-heparin.",
"   </p>",
"   <p>",
"    Recombinant TFPI is currently being evaluated as one of several new anticoagulants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/112\">",
"     112",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37818?source=see_link&amp;anchor=H25#H25\">",
"     \"Anticoagulants other than heparin and warfarin\", section on 'Tissue factor and factor VII as potential targets'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Prostacyclin and thromboxane",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intact endothelial cells in proximity to disrupted endothelium release arachidonic acid from cell membrane phospholipids by phospholipase A2. The enzyme cyclooxygenase-1 (COX-1 or prostaglandin endoperoxide H synthase-1) converts arachidonic acid into thromboxane A2 (TxA2) in platelets, while prostacyclin (PGI2), a dominant product of the endothelium, appears to largely derive from COX-2, the production of which is induced by laminar blood flow under physiologic conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/113,114\">",
"     113,114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TxA2 is a potent stimulator of platelet aggregation and produces vasoconstriction, while PGI2, via activation of adenylate cyclase, blocks platelet aggregation and antagonizes TxA2-mediated vasoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/115\">",
"     115",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1336?source=see_link&amp;anchor=H6#H6\">",
"     \"NSAIDs: Mechanism of action\", section on 'COX enzymes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      irreversibly acetylates and inhibits COX-1 and only weakly inhibits COX-2 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/116\">",
"       116",
"      </a>",
"      ]. Since platelets cannot make new COX-1, the inhibition of TxA2 is permanent for the life of the platelet.",
"     </li>",
"     <li>",
"      In comparison, endothelial cells can make new COX-1 as well as COX-2 and higher doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      are required for inhibition of PGI2 production [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/117\">",
"       117",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This distinction underlies the hypothesized mechanism for the benefit of low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    in cardiovascular disease, as well as the increased cardiac toxicity of the selective COX-2 inhibitors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=see_link\">",
"     \"Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Nitric oxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitric oxide (NO) is formed from L-arginine in endothelial cells, catalyzed by the enzyme nitric oxide synthase (NOS) (",
"    <a class=\"graphic graphic_figure graphicRef79786 \" href=\"UTD.htm?27/52/28494\">",
"     figure 5",
"    </a>",
"    ). Acting through guanylate cyclase and cGMP, it causes vasodilatation and inhibits platelet adhesion and aggregation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/118\">",
"     118",
"    </a>",
"    ]. NO is rapidly destroyed by hemoglobin and therefore functions as a local (paracrine) hormone.",
"   </p>",
"   <p>",
"    Intravenous infusion of an arginine analog which blocks NO production leads to an immediate and substantial rise in blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/119\">",
"     119",
"    </a>",
"    ], suggesting that there is a continual, basal release of NO to regulate vascular tone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     CLOT ELIMINATION AND FIBRINOLYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;To restore vessel patency following hemostasis, the clot must be organized and removed by the proteolytic enzyme plasmin in conjunction with wound healing and tissue remodeling. Plasminogen, the precursor molecule to plasmin, binds fibrin and tissue plasminogen activator (tPA). This ternary complex leads to conversion of the proenzyme plasminogen to active, proteolytic plasmin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/120,121\">",
"     120,121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plasmin has broad substrate specificity and, in addition to fibrin, cleaves fibrinogen and a variety of plasma proteins and clotting factors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/122\">",
"     122",
"    </a>",
"    ]. Plasmin cleaves the polymerized fibrin strand at multiple sites and releases fibrin degradation products (FDPs). One of the major FDPs is D-dimer, which consists of two D domains from adjacent fibrin monomers that have been crosslinked by activated factor XIII (",
"    <a class=\"graphic graphic_figure graphicRef62012 \" href=\"UTD.htm?20/39/21119\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     plasminogen/plasminogen-activator",
"    </span>",
"    system is complex, paralleling the coagulation cascade (",
"    <a class=\"graphic graphic_figure graphicRef81428 \" href=\"UTD.htm?30/24/31118\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/123\">",
"     123",
"    </a>",
"    ]. Plasmin activity is regulated by vascular endothelial cells that secrete both serine protease plasminogen activators (tissue-type plasminogen activator and urokinase-type plasminogen activator) and plasminogen activator inhibitors (PAI-1 and PAI-2). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21450?source=see_link\">",
"     \"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Tissue-type plasminogen activator",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tPA molecule is predominantly an endothelial cell enzyme. Its release is stimulated by a variety of substances including thrombin, serotonin, bradykinin, cytokines, and epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/124,125\">",
"     124,125",
"    </a>",
"    ]. In plasma it circulates as a complex with its natural inhibitor PAI-1 and is rapidly cleared by the liver.",
"   </p>",
"   <p>",
"    Analogous to the prothrombin complex, the rapid generation of plasmin by tPA optimally takes place on a surface, the fibrin clot. Both tPA and fibrinogen bind to fibrin via recognition of lysine residues in the fibrin clot. When bound to fibrin, the binding interaction aligns tPA and plasminogen on the fibrin surface [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/126\">",
"     126",
"    </a>",
"    ] so that the catalytic efficiency of tPA is increased several hundred-fold [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Urokinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urokinase is the second physiologic plasminogen activator. It is present in high concentration in the urine. While tPA is largely responsible for initiating intravascular fibrinolysis, urokinase is the major activator of fibrinolysis in the extravascular compartment. Urokinase is secreted by many cell types in the form of prourokinase, also termed single-chain urokinase-type plasminogen activator (scu-PA). Prourokinase is converted to urokinase by plasmin; it has a low level of proteolytic activity unless it is exposed to fibrin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Plasminogen activator inhibitors and alpha-2-antiplasmin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The PAIs inhibit tPA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/127,128\">",
"     127,128",
"    </a>",
"    ], while alpha-2-antiplasmin inhibits plasmin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PAI-1 is synthesized by endothelial cells and platelets which regulate its release during fibrinolysis. Patients deficient in PAI-1 have a bleeding diathesis usually related to trauma or surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/130,131\">",
"       130,131",
"      </a>",
"      ]. The release of PAI-1 by activated platelets may contribute to the relative resistance of platelet-rich arterial thrombi to thrombolysis.",
"     </li>",
"     <li>",
"      PAI-2 is synthesized by white blood cells and the placenta and its levels are greatly increased during pregnancy. PAI-2 is less effective as a plasminogen inhibitor [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/132\">",
"       132",
"      </a>",
"      ] and its biologic importance is uncertain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alpha-2-antiplasmin is secreted by the liver and is also present within platelets [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/133\">",
"     133",
"    </a>",
"    ]. It can be crosslinked into the fibrin clot by factor XIIIa, and plays an important role in making thrombi resistant to plasmin by complexing with it. Plasmin released into the circulation is rapidly inactivated by alpha-2-antiplasmin. However, alpha-2-antiplasmin is present in lower concentrations than is plasminogen and therefore can become depleted while plasmin is continuing to be generated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Thrombin-activatable fibrinolysis inhibitor",
"    </span>",
"    &nbsp;&mdash;&nbsp;When fibrin is degraded by plasmin, new carboxy-terminal lysines are exposed in the partially digested clot. These residues provide additional sites for plasminogen incorporation into the clot, creating a positive feedback loop in clot lysis. The carboxy-terminal lysines are susceptible to removal by carboxypeptidases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/134,135\">",
"     134,135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A proenzyme form of carboxypeptidase-B, called thrombin-activatable fibrinolysis inhibitor (TAFI), circulates in plasma. TAFI is a physiologic substrate for the thrombin-thrombomodulin (TM) complex [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/136,137\">",
"     136,137",
"    </a>",
"    ]. Similar to protein C, the activation of TAFI by the thrombin-TM complex is approximately 1000-fold faster than with free thrombin alone [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/138,139\">",
"     138,139",
"    </a>",
"    ]. Activated TAFI functions as a fibrinolysis inhibitor by cleavage of C-terminal lysines from partially digested fibrin, thereby diminishing the incorporation and activation of plasminogen, leading to delayed clot lysis.",
"   </p>",
"   <p>",
"    Factor XIIIa may crosslink TAFI to fibrin, helping to protect the newly formed fibrin from premature plasmin degradation. Crosslinking may also facilitate the activation of TAFI, stabilize enzymatic activity, and protect the active enzyme from further degradation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/140\">",
"     140",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    From a physiologic standpoint, one can envisage that upon thrombin binding to TM, the thrombin-TM complex will activate protein C to dampen the clotting cascade, and will also activate TAFI, thereby protecting the clot already formed at the vascular wound from premature degradation. The concentration of thrombin required for the activation of TAFI is substantially higher than that for fibrinogen clotting. Thus, TAFI activation requires amplification and acceleration of thrombin generation through feedback activation of factors V, VIII, and XI by the small amount of initially generated thrombin (",
"    <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This requirement for adequate activation of TAFI can have important clinical consequences in a number of acquired and congenital disorders of coagulation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The bleeding diathesis encountered in hemophiliacs (eg, factor VIII deficiency) and patients deficient in factor XI may be partly related to suboptimal activation of TAFI, leading to enhanced and premature clot lysis (",
"      <a class=\"graphic graphic_algorithm graphicRef62974 \" href=\"UTD.htm?31/46/32494\">",
"       algorithm 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/87,88,141-144\">",
"       87,88,141-144",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/14/37097?source=see_link&amp;anchor=H3#H3\">",
"       \"Factor XI deficiency\", section on 'Role in coagulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The low levels of TAFI seen in patients with chronic liver disease may be responsible, in part, for the low-grade fibrinolysis seen in this condition [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/145\">",
"       145",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Enhanced thrombin generation in patients with the G20210A prothrombin gene mutation may lead to increased activation of TAFI, resulting in inhibition of fibrinolysis and increased thrombotic risk [",
"      <a class=\"abstract\" href=\"UTD.htm?26/35/27194/abstract/146\">",
"       146",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20743?source=see_link\">",
"       \"Prothrombin gene mutation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19117173\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the pathways of clot formation and clot lysis are appropriately linked (",
"    <a class=\"graphic graphic_figure graphicRef69920 \" href=\"UTD.htm?31/51/32574\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef81428 \" href=\"UTD.htm?30/24/31118\">",
"     figure 2",
"    </a>",
"    ), a clot is laid down initially to stop bleeding, followed later by clot lysis and tissue remodeling. Abnormal bleeding can result from diminished clot generation or enhanced clot lysis, while excessive clot formation or reduced clot lysis can lead to excessive thrombosis. The following phases coordinate this overall process. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Phases of the hemostatic process'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Formation of the platelet plug",
"      </strong>",
"      ��� Platelets are activated at the site of vascular injury to form a platelet plug that provides the initial hemostatic response, including exposure of procoagulant phospholipids on the platelet surface and the assembly of components of the clotting cascade. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Formation of the platelet plug'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Clot formation",
"      </strong>",
"      ��� Generation or exposure of tissue factor at the wound site, its interaction with factor VII and the subsequent generation of activated factor X, are the primary physiologic events in initiating clotting, while components of the intrinsic pathway (ie, factors VIII, IX, XI) are responsible for amplification of this process. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clotting cascade and propagation of the clot'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Termination of clotting",
"      </strong>",
"      ��� The termination phase of coagulation involves antithrombin, tissue factor pathway inhibitor and the protein C pathway. This phase is critical in mediating the extent of clot formation, as demonstrated by the thrombotic disorders present in individuals with abnormalities in this pathway. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Control mechanisms and termination of clotting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Clot lysis",
"      </strong>",
"      ��� To restore vessel patency, the clot must be organized and removed. Plasminogen binds fibrin and tissue plasminogen activator (tPA) leading to active, proteolytic plasmin, which cleaves fibrin, fibrinogen, and a variety of plasma proteins and clotting factors. The",
"      <span class=\"nowrap\">",
"       plasminogen/plasminogen-activator",
"      </span>",
"      system is complex, paralleling the coagulation cascade (",
"      <a class=\"graphic graphic_figure graphicRef81428 \" href=\"UTD.htm?30/24/31118\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Clot elimination and fibrinolysis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/1\">",
"      Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106:2605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/2\">",
"      Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/3\">",
"      Watson SP. Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost 1999; 82:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/4\">",
"      Coughlin SR. Protease-activated receptors and platelet function. Thromb Haemost 1999; 82:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/5\">",
"      Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/6\">",
"      Brass LF. Thrombin and platelet activation. Chest 2003; 124:18S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/7\">",
"      Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006; 114:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/8\">",
"      Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/9\">",
"      Dubois C, Panicot-Dubois L, Gainor JF, et al. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest 2007; 117:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/10\">",
"      Clemetson KJ. Platelet GPIb-V-IX complex. Thromb Haemost 1997; 78:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/11\">",
"      L&oacute;pez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard-Soulier syndrome. Blood 1998; 91:4397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/12\">",
"      Sixma JJ, van Zanten GH, Huizinga EG, et al. Platelet adhesion to collagen: an update. Thromb Haemost 1997; 78:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/13\">",
"      Savage B, Sald&iacute;var E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/14\">",
"      Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/15\">",
"      Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267:11300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/16\">",
"      Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood 1998; 91:2645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/17\">",
"      Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008; 112:3011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/18\">",
"      Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999; 103:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/19\">",
"      Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/20\">",
"      Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998; 98:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/21\">",
"      Harrison P, Savidge GF, Cramer EM. The origin and physiological relevance of alpha-granule adhesive proteins. Br J Haematol 1990; 74:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/22\">",
"      Reinhardt C, von Br&uuml;hl ML, Manukyan D, et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008; 118:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/23\">",
"      Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008; 118:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/24\">",
"      Kojima H, Newton-Nash D, Weiss HJ, et al. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 1994; 94:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/25\">",
"      Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 2005; 3:2633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/26\">",
"      Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93:1798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/27\">",
"      Rapaport SI, Rao LV. The tissue factor pathway: how it has become a \"prima ballerina\". Thromb Haemost 1995; 74:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/28\">",
"      Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis 2006; 36:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/29\">",
"      Camire RM, Bos MH. The molecular basis of factor V and VIII procofactor activation. J Thromb Haemost 2009; 7:1951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/30\">",
"      Vandendries ER, Hamilton JR, Coughlin SR, et al. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A 2007; 104:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/31\">",
"      Butenas S, van 't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 1997; 272:21527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/32\">",
"      Jesty J, Spencer AK, Nemerson Y. The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X. J Biol Chem 1974; 249:5614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/33\">",
"      Baugh RJ, Krishnaswamy S. Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex. J Biol Chem 1996; 271:16126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/34\">",
"      Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977; 74:5260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/35\">",
"      Morrison SA, Jesty J. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood 1984; 63:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/36\">",
"      Rosing J, van Rijn JL, Bevers EM, et al. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/37\">",
"      Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006; 13:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/38\">",
"      Sims PJ, Wiedmer T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264:17049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/39\">",
"      Toti F, Satta N, Fressinaud E, et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996; 87:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/40\">",
"      Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998; 92:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/41\">",
"      Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/42\">",
"      Yang H, Kim A, David T, et al. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 2012; 151:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/43\">",
"      B&auml;chli E. History of tissue factor. Br J Haematol 2000; 110:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/44\">",
"      Mandal SK, Pendurthi UR, Rao LV. Cellular localization and trafficking of tissue factor. Blood 2006; 107:4746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/45\">",
"      Chen VM, Ahamed J, Versteeg HH, et al. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006; 45:12020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/46\">",
"      Wong JW, Hogg PJ. Analysis of disulfide bonds in protein structures. J Thromb Haemost 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/47\">",
"      Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol 2009; 29:1989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/48\">",
"      Bach RR, Monroe D. What is wrong with the allosteric disulfide bond hypothesis? Arterioscler Thromb Vasc Biol 2009; 29:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/49\">",
"      Kothari H, Nayak RC, Rao LV, Pendurthi UR. Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood 2010; 115:4273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/50\">",
"      Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96:2311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/51\">",
"      Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/52\">",
"      Del Conde I, Shrimpton CN, Thiagarajan P, L&oacute;pez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/53\">",
"      Panes O, Matus V, S&aacute;ez CG, et al. Human platelets synthesize and express functional tissue factor. Blood 2007; 109:5242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/54\">",
"      Bouchard BA, Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood 2010; 116:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/55\">",
"      Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost 2001; 86:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/56\">",
"      Konigsberg W, Kirchhofer D, Riederer MA, Nemerson Y. The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost 2001; 86:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/57\">",
"      Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 1995; 46:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/58\">",
"      Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci U S A 1988; 85:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/59\">",
"      Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266:7353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/60\">",
"      von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86:3035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/61\">",
"      Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science 1991; 253:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/62\">",
"      Di Scipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest 1978; 61:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/63\">",
"      Sun Y, Gailani D. Identification of a factor IX binding site on the third apple domain of activated factor XI. J Biol Chem 1996; 271:29023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/64\">",
"      Mann KG, Krishnaswamy S, Lawson JH. Surface-dependent hemostasis. Semin Hematol 1992; 29:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/65\">",
"      Suzuki K, Dahlb&auml;ck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257:6556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/66\">",
"      Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/67\">",
"      Mann KG, Nesheim ME, Hibbard LS, Tracy PB. The role of factor V in the assembly of the prothrombinase complex. Ann N Y Acad Sci 1981; 370:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/68\">",
"      Tracy PB, Giles AR, Mann KG, et al. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency. J Clin Invest 1984; 74:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/69\">",
"      Kane WH, Lindhout MJ, Jackson CM, Majerus PW. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem 1980; 255:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/70\">",
"      Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/71\">",
"      Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992; 29:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/72\">",
"      Pisano JJ, Finlayson JS, Peyton MP. [Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine]. Science 1968; 160:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/73\">",
"      Greenberg CS, Achyuthan KE, Fenton JW 2nd. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. Blood 1987; 69:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/74\">",
"      Kornberg A, Rao NN, Ault-Rich&eacute; D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem 1999; 68:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/75\">",
"      Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 2004; 279:44250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/76\">",
"      Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012; 119:5972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/77\">",
"      L&auml;mmle B, Wuillemin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991; 65:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/78\">",
"      Colman RW, Bagdasarian A, Talamo RC, et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975; 56:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/79\">",
"      Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/80\">",
"      Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011; 118:6963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/81\">",
"      Renn&eacute; T, Pozgajov&aacute; M, Gr&uuml;ner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/82\">",
"      Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 2002; 87:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/83\">",
"      Salomon O, Steinberg DM, Koren-Morag N, et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008; 111:4113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/84\">",
"      Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, et al. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy. J Thromb Haemost 2007; 5:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/85\">",
"      Reuner KH, Jenetzky E, Aleu A, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology 2008; 70:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/86\">",
"      Tirado I, Soria JM, Mateo J, et al. Association after linkage analysis indicates that homozygosity for the 46C--&gt;T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004; 91:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/87\">",
"      Von dem Borne PA, Bajzar L, Meijers JC, et al. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 1997; 99:2323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/88\">",
"      Minnema MC, Friederich PW, Levi M, et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J Clin Invest 1998; 101:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/89\">",
"      Perry DJ. Antithrombin and its inherited deficiencies. Blood Rev 1994; 8:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/90\">",
"      Marcum JA, McKenney JB, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest 1984; 74:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/91\">",
"      Mammen EF. Antithrombin: its physiological importance and role in DIC. Semin Thromb Hemost 1998; 24:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/92\">",
"      Weitz JI. Heparan sulfate: antithrombotic or not? J Clin Invest 2003; 111:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/93\">",
"      Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 257:7944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/94\">",
"      Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264:4743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/95\">",
"      Esmon CT. The protein C pathway. Chest 2003; 124:26S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/96\">",
"      Dutt T, Toh CH. The Yin-Yang of thrombin and activated protein C. Br J Haematol 2008; 140:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/97\">",
"      Esmon CT, Xu J, Gu JM, et al. Endothelial protein C receptor. Thromb Haemost 1999; 82:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/98\">",
"      Taylor FB Jr, Peer GT, Lockhart MS, et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 2001; 97:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/99\">",
"      Saposnik B, Reny JL, Gaussem P, et al. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 2004; 103:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/100\">",
"      Isermann B, Hendrickson SB, Zogg M, et al. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. J Clin Invest 2001; 108:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/101\">",
"      Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256:11128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/102\">",
"      Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in factor VR506Q. J Biol Chem 1995; 270:4053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/103\">",
"      Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood 1984; 63:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/104\">",
"      O'Brien LM, Mastri M, Fay PJ. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase. Blood 2000; 95:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/105\">",
"      Thorelli E, Kaufman RJ, Dahlb&auml;ck B. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 1999; 93:2552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/106\">",
"      Castoldi E, Brugge JM, Nicolaes GA, et al. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations. Blood 2004; 103:4173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/107\">",
"      Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001; 86:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/108\">",
"      Broze GJ Jr, Warren LA, Novotny WF, et al. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/109\">",
"      Baugh RJ, Broze GJ Jr, Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998; 273:4378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/110\">",
"      Jesty J, Wun TC, Lorenz A. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry 1994; 33:12686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/111\">",
"      Caplice NM, Panetta C, Peterson TE, et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001; 98:2980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/112\">",
"      Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost 1997; 78:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/113\">",
"      Topper JN, Cai J, Falb D, Gimbrone MA Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 1996; 93:10417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/114\">",
"      Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006; 116:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/115\">",
"      Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989; 259:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/116\">",
"      Phillips DR, Conley PB, Sinha U, Andre P. Therapeutic approaches in arterial thrombosis. J Thromb Haemost 2005; 3:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/117\">",
"      Clarke RJ, Mayo G, Price P, FitzGerald GA. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med 1991; 325:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/118\">",
"      Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/119\">",
"      Qiu C, Muchant D, Beierwaltes WH, et al. Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension 1998; 31:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/120\">",
"      Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost 1980; 43:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/121\">",
"      Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257:2912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/122\">",
"      Samis JA, Ramsey GD, Walker JB, et al. Proteolytic processing of human coagulation factor IX by plasmin. Blood 2000; 95:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/123\">",
"      Kolev K, Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003; 89:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/124\">",
"      Stein CM, Brown N, Vaughan DE, et al. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/125\">",
"      Yamamoto C, Kaji T, Sakamoto M, et al. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb Res 1994; 74:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/126\">",
"      van Zonneveld AJ, Veerman H, Pannekoek H. Autonomous functions of structural domains on human tissue-type plasminogen activator. Proc Natl Acad Sci U S A 1986; 83:4670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/127\">",
"      Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/128\">",
"      Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: An update. Fibrinolysis 1995; 9:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/129\">",
"      Edelberg JM, Pizzo SV. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin. Biochem J 1992; 286 ( Pt 1):79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/130\">",
"      Fay WP, Shapiro AD, Shih JL, et al. Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 1992; 327:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/131\">",
"      Fay WP, Parker AC, Condrey LR, Shapiro AD. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood 1997; 90:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/132\">",
"      Schwartz BS. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism. J Biol Chem 1994; 269:8319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/133\">",
"      Favier R, Aoki N, de Moerloose P. Congenital alpha(2)-plasmin inhibitor deficiencies: a review. Br J Haematol 2001; 114:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/134\">",
"      Nesheim M. Fibrinolysis and the plasma carboxypeptidase. Curr Opin Hematol 1998; 5:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/135\">",
"      Redlitz A, Tan AK, Eaton DL, Plow EF. Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 1995; 96:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/136\">",
"      Booth NA. TAFI meets the sticky ends. Thromb Haemost 2001; 85:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/137\">",
"      Binette TM, Taylor FB Jr, Peer G, Bajzar L. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Blood 2007; 110:3168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/138\">",
"      Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271:16603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/139\">",
"      Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001; 85:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/140\">",
"      Valnickova Z, Enghild JJ. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin. J Biol Chem 1998; 273:27220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/141\">",
"      Mosnier LO, Lisman T, van den Berg HM, et al. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001; 86:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/142\">",
"      Broze GJ Jr, Higuchi DA. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 1996; 88:3815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/143\">",
"      Lisman T, Mosnier LO, Lambert T, et al. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Blood 2002; 99:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/144\">",
"      Foley JH, Nesheim ME. Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. J Thromb Haemost 2009; 7:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/145\">",
"      Van Thiel DH, George M, Fareed J. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease. Thromb Haemost 2001; 85:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/35/27194/abstract/146\">",
"      Colucci M, Binetti BM, Tripodi A, et al. Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism. Blood 2004; 103:2157.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1371 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-71A5527948-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27194=[""].join("\n");
var outline_f26_35_27194=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19117173\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHASES OF THE HEMOSTATIC PROCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      FORMATION OF THE PLATELET PLUG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Platelet activation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Collagen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Thrombin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Platelet adhesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Platelet aggregation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Platelet secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Procoagulant activity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLOTTING CASCADE AND PROPAGATION OF THE CLOT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Thrombin generation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Multicomponent complexes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Extrinsic pathway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H603267846\">",
"      - Tissue factor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H603267853\">",
"      - Activation of factors VII, X, and IX",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H603267860\">",
"      - Continuation of the coagulation cascade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Intrinsic pathway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H349234200\">",
"      - Critical role of polyphosphate in initiating blood clotting via the intrinsic pathway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Deficiencies of initial intrinsic pathway proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CONTROL MECHANISMS AND TERMINATION OF CLOTTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Antithrombin, heparin, and heparan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Activated protein C and protein S",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Tissue factor pathway inhibitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Prostacyclin and thromboxane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nitric oxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      CLOT ELIMINATION AND FIBRINOLYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Tissue-type plasminogen activator",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Urokinase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Plasminogen activator inhibitors and alpha-2-antiplasmin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Thrombin-activatable fibrinolysis inhibitor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19117173\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1371\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1371|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?31/46/32494\" title=\"algorithm 1\">",
"      Thrombin generation pathways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1371|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/51/32574\" title=\"figure 1\">",
"      Coagulation cascade",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/24/31118\" title=\"figure 2\">",
"      Regulation of fibrinolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/20/12610\" title=\"figure 3\">",
"      Tissue factor and coagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/16/36110\" title=\"figure 4\">",
"      Mechanisms of action of heparin LMW heparin and fondaparinux",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/52/28494\" title=\"figure 5\">",
"      Formation of NO by NOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/39/21119\" title=\"figure 6\">",
"      Fibrin polymerization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1371|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/43/2748\" title=\"table 1\">",
"      Features of bleeding disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/35/28218?source=related_link\">",
"      Activated protein C resistance and factor V Leiden",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37818?source=related_link\">",
"      Anticoagulants other than heparin and warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=related_link\">",
"      Approach to the adult patient with a bleeding diathesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37066?source=related_link\">",
"      Benefits and risks of aspirin in secondary and primary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/41/17049?source=related_link\">",
"      Biology and normal function of von Willebrand factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/36/4682?source=related_link\">",
"      Clinical use of coagulation tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8218?source=related_link\">",
"      Disorders of fibrinogen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=related_link\">",
"      Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/41/11930?source=related_link\">",
"      Evaluation of the patient with established venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/14/37097?source=related_link\">",
"      Factor XI deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1336?source=related_link\">",
"      NSAIDs: Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1224?source=related_link\">",
"      Pathogenesis of the hypercoagulable state associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/7/1146?source=related_link\">",
"      Platelet biology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/59/23482?source=related_link\">",
"      Platelet function testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20743?source=related_link\">",
"      Prothrombin gene mutation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=related_link\">",
"      The role of platelets in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33930?source=related_link\">",
"      Therapeutic use of heparin and low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/60/21450?source=related_link\">",
"      Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5080?source=related_link\">",
"      Type III hereditary angioedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/32/20999?source=related_link\">",
"      Vitamin K, gamma carboxyglutamic acid, and the function of coagulation and other proteins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_35_27195="Causes of oligohydramnios";
var content_f26_35_27195=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79447&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of oligohydramnios",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Maternal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medical or obstetrical conditions associated with uteroplacental insufficiency (eg, preeclampsia, chronic hypertension, collagen vascular disease, nephropathy, thrombophilia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medications (eg, angiotensin converting enzyme inhibitors, prostaglandin synthetase inhibitors, trastuzumab)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Placental",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abruption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Twin to twin transfusion (ie, twin polyhydramnios-oligohydramnios sequence)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placental thrombosis or infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fetal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chromosomal abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital abnormalities, especially those associated with impaired urine production",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Demise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postterm pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ruptured fetal membranes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Idiopathic",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27195=[""].join("\n");
var outline_f26_35_27195=null;
var title_f26_35_27196="Lesion-specific characteristics and outcome after balloon angiop";
var content_f26_35_27196=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lesion-specific characteristics and outcome after balloon angioplasty",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Type A lesions- high success (&gt;85 percent); low risk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Discrete, &lt;10 mm in length",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Concentric",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Readily accessible",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nonangulated segment, &lt;45&deg;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Smooth contour",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Little or no calcification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Less than totally occlusive",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Not ostial in location",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       No major branch involvement",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Absence of thrombus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Type B lesions- moderate success (60 to 85 percent); moderate risk (Type B1 - one type B characteristic; Type B2 - more than one type B characteristic)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tubular, 10 to 20 mm in length",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Eccentric",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Moderate tortuosity of proximal segment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Moderately angulated segment (&gt;45&deg;, &lt;90&deg;)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Irregular contour",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Moderate to heavy calcification",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Total occlusions less than three months old and/or bridging collaterals",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ostial in location",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bifurcation lesions requiring double guide wires",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Some thrombus present",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Type C lesions- low success (&lt;60 percent); high risk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diffuse, &gt;20 mm in length",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Excessive tortuosity of proximal segment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Extremely angulated segments &gt;90&deg;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Total occlusion  more than three months old",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inability to protect major side branches",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Degenerated vein grafts with friable lesions",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Although the risk of abrupt vessel closure is moderate, in certain instances the likelihood of a major complication may be low with dilation of total occlusions less than three months old or when abundant collateral channels supply the distal vessel.",
"    </div>",
"    <div class=\"reference\">",
"     From Ryan TO, Axon DP, Gunnar RM, et al. J Am Coll Cardiol 1988; 12:529.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27196=[""].join("\n");
var outline_f26_35_27196=null;
var title_f26_35_27197="ESWL clinical results";
var content_f26_35_27197=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical results of endoscopy and ESWL for pancreatic stones",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Author year",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Complete or partial pain relief, percent",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Overall increase in BW, percent",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Exocrine function",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Endocrine function",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Need for surgery, percent",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Mean follow-up, months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Improved percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Worsened percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Improved percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Worsened percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delhaye 1992",
"       </td>",
"       <td>",
"        123",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sauerbruch 1992",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        83",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schneider 1994",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Johanns 1996",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        83",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ohara 1996",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        86",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        44",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Costamagna 1997",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adamek 1999",
"       </td>",
"       <td>",
"        80",
"       </td>",
"       <td>",
"        76",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        47",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brand 2000",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        82",
"       </td>",
"       <td>",
"        68",
"       </td>",
"       <td>",
"        77",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kozarek 2002",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        80",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inui 2005",
"       </td>",
"       <td>",
"        504",
"       </td>",
"       <td>",
"        91",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        44",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tadenuma 2005",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        77",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seven 2012",
"       </td>",
"       <td>",
"        120",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        12&nbsp;",
"       </td>",
"       <td>",
"        52",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BW: body weight.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27197=[""].join("\n");
var outline_f26_35_27197=null;
var title_f26_35_27198="Overview of diagnostic criteria for gestational diabetes";
var content_f26_35_27198=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F87282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F87282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Overview of diagnostic criteria and plasma glucose thresholds for gestational diabetes mellitus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"8\" width=\"12%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Organization",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Year",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Testing schedule",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Abnormal value(s)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Threshold (equal to or greater than)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        0 (h)",
"       </td>",
"       <td class=\"subtitle2\">",
"        1 (h)",
"       </td>",
"       <td class=\"subtitle2\">",
"        2 (h)",
"       </td>",
"       <td class=\"subtitle2\">",
"        3 (h)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <p>",
"         ADA (low risk* excluded)",
"        </p>",
"       </td>",
"       <td rowspan=\"2\">",
"        2000-2010",
"       </td>",
"       <td>",
"        50 g OGCT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        130 mg/dL",
"        <br/>",
"        7.2 mmol/L",
"        <br/>",
"        or 140 mg/dL",
"        <br/>",
"        7.8 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g or 75 g OGTT after overnight fast &ge;8hr",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        95 mg/dL",
"        <br/>",
"        5.3 mmol/L",
"       </td>",
"       <td>",
"        180 mg/dL",
"        <br/>",
"        10.0 mmol/L",
"       </td>",
"       <td>",
"        155 mg/dL",
"        <br/>",
"        8.6 mmol/L",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L (3 hr value only for 100 g test)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         IADPSG",
"        </p>",
"        ADA",
"       </td>",
"       <td>",
"        2011",
"       </td>",
"       <td>",
"        75 g OGTT",
"       </td>",
"       <td>",
"        1 or more",
"       </td>",
"       <td>",
"        92 mg/dL",
"        <br/>",
"        5.1 mmol/L",
"       </td>",
"       <td>",
"        180 mg/dL",
"        <br/>",
"        10.0 mmol/L",
"       </td>",
"       <td>",
"        153 mg/dL",
"        <br/>",
"        8.5 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        CC",
"       </td>",
"       <td rowspan=\"2\">",
"        2007",
"       </td>",
"       <td>",
"        50 g OGCT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        130 mg/dL",
"        <br/>",
"        7.2 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g OGTT",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        95 mg/dL",
"        <br/>",
"        5.3 mmol/L",
"       </td>",
"       <td>",
"        180 mg/dL",
"        <br/>",
"        10.0 mmol/L",
"       </td>",
"       <td>",
"        155 mg/dL",
"        <br/>",
"        8.6 mmol/L",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        NDDG",
"       </td>",
"       <td rowspan=\"2\">",
"        1979",
"       </td>",
"       <td>",
"        50 g OGCT",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g OGTT",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        105 mg/dL",
"        <br/>",
"        5.8 mmol/L",
"       </td>",
"       <td>",
"        190 mg/dL",
"        <br/>",
"        10.5 mmol/L",
"       </td>",
"       <td>",
"        165 mg/dL",
"        <br/>",
"        9.1 mmol/L",
"       </td>",
"       <td>",
"        145 mg/dL",
"        <br/>",
"        8.0 mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        WHO",
"       </td>",
"       <td>",
"        1999 WHO consultation",
"       </td>",
"       <td>",
"        75 g OGTT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        6.1 mmol/L for IGT of pregnancy; 7.0 mmol/L for Dx of DM",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L for IGT of pregnancy; 200 mg/dL 11.1 mmol/L for Dx of DM",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        CDA",
"       </td>",
"       <td rowspan=\"2\">",
"        2003, 2008",
"       </td>",
"       <td>",
"        50 g OGCT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L or 186 mg/dL, 10.3 mmol/L Dx GDM",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        75 g",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        95 mg/dL",
"        <br/>",
"        5.3 mmol/L",
"       </td>",
"       <td>",
"        191 mg/dL",
"        <br/>",
"        10.6 mmol/L",
"       </td>",
"       <td>",
"        160 mg/dL",
"        <br/>",
"        8.9 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        ACOG - risk factor",
"        <br/>",
"        4th IWC",
"       </td>",
"       <td rowspan=\"3\">",
"        2001",
"       </td>",
"       <td>",
"        50 g",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        130 mg/dL",
"        <br/>",
"        7.2 mmol/L",
"        <br/>",
"        or 140 mg/dL",
"        <br/>",
"        7.8 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g CC",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        95 mg/dL",
"        <br/>",
"        5.3 mmol/L",
"       </td>",
"       <td>",
"        180 mg/dL",
"        <br/>",
"        10.0 mmol/L",
"       </td>",
"       <td>",
"        155 mg/dL",
"        <br/>",
"        8.5 mmol/L",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g NDDG",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        105 mg/dL",
"        <br/>",
"        5.8 mmol/L",
"       </td>",
"       <td>",
"        190 mg/dL",
"        <br/>",
"        10.5 mmol/L",
"       </td>",
"       <td>",
"        165 mg/dL",
"        <br/>",
"        9.1 mmol/L",
"       </td>",
"       <td>",
"        145 mg/dL",
"        <br/>",
"        8.0 mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3rd IWC",
"       </td>",
"       <td>",
"        1991",
"       </td>",
"       <td>",
"        100 g OGTT",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        105 mg/dL",
"        <br/>",
"        5.8 mmol/L",
"       </td>",
"       <td>",
"        190 mg/dL",
"        <br/>",
"        10.5 mmol/L",
"       </td>",
"       <td>",
"        165 mg/dL",
"        <br/>",
"        9.1 mmol/L",
"       </td>",
"       <td>",
"        145 mg/dL",
"        <br/>",
"        8.0 mmol/L",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        ADIPS",
"       </td>",
"       <td rowspan=\"2\">",
"        1998",
"       </td>",
"       <td>",
"        50 g or 75 g nonfasting",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        140 mg/dL",
"        <br/>",
"        7.8 mmol/L (50 g)",
"        <br/>",
"        or 144 mg/dL",
"        <br/>",
"        8.0 mmol/L (75 g)",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        75 g fasting",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        99 mg/dL",
"        <br/>",
"        5.5 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        144 mg/dL",
"        <br/>",
"        8.0 mmol/L",
"        <br/>",
"        or 162 mg/dL",
"        <br/>",
"        9.0 mmol/L",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        EASD",
"       </td>",
"       <td>",
"        1996",
"       </td>",
"       <td>",
"        75 g",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        108 mg/dL",
"        <br/>",
"        6.0 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        162 mg/dL",
"        <br/>",
"        9.0 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        USPSTF (grade 1 recommendation)",
"       </td>",
"       <td rowspan=\"2\">",
"        2008",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Risk assessment 50 g OGCT",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        130 mg/dL",
"        <br/>",
"        7.2 mmol/L",
"        <br/>",
"        or 140 mg/dL",
"        <br/>",
"        7.8 mmol/L",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 g OGTT",
"       </td>",
"       <td>",
"        2 or more",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ACOG: American College of Obstetricians and Gynecologists; ADA: American Diabetes Association; ADIPS: Australasian Diabetes in Pregnancy Society; CC: Carpenter, Coustan; CDA: Canadian Diabetes Association; DM: diabetes mellitus; Dx: diagnosis; EASD: European Association for the Study of Diabetes; GDM: gestational diabetes mellitus; IADPSG: International Association of Diabetes in Pregnancy Study Groups; IGT: impaired glucose tolerance; IWC: International Workshop Conference; NDDG: National Diabetes Data Group; NR: not reported; OGCT: oral glucose challenge test; OGTT: oral glucose tolerance test; USPSTF: United States Preventive Services Task Force; WHO: World Health Organization.",
"     <br>",
"      * Low risk defined as age &lt;25 years, normal body weight, no first degree relative with DM, no history of abnormal glucose, no history of poor obstetrical outcomes, not of high risk ethnicity for DM.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       In New Zealand.",
"       <br>",
"        <sup>",
"         &Delta;",
"        </sup>",
"        US Preventive Services Task Force. Screening for gestational diabetes mellitus: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148:759.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Evidence Report/Technology Assessment. Number 10. Screening and diagnosing gestational diabetes mellitus. October 2012. AHRQ Publication No. 12(13)-E021-EF.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27198=[""].join("\n");
var outline_f26_35_27198=null;
var title_f26_35_27199="Spermatocele";
var content_f26_35_27199=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spermatocele",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A spermatocele epididymal cyst is a painless, fluid-filled cyst of the epididymis. It can be palpated as distinct from the testis and typically transilluminates as a cystic mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_35_27199=[""].join("\n");
var outline_f26_35_27199=null;
